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Abstract of the Dissertation 
Molecular adaptations within the medial habenula circuitry regulate cocaine-associated 
behaviors. 
 
By 
Alberto J. López 
 
Doctor of Philosophy in Biological Sciences 
University of California, Irvine, 2018 
Professor Marcelo Wood, Chair 
 
Drugs of abuse, such as cocaine, are known to cause long-term changes in reward circuitry 
and, ultimately, persistent changes in behavior. Although many critical nodes in the neural 
circuitry contributing to relapse of drug-seeking behavior have been identified and studied, a full 
characterization of the networks driving reinstatement of cocaine-seeking remains lacking. One 
area that may provide further insight to the mechanisms of relapse is the habenula complex, an 
epithalamic region composed of lateral (LHb) and medial (MHb) substructures. Recent research 
has demonstrated a role for the MHb in regulating drug-associated behavior; specifically, the MHb 
has been shown to be a regulator of nicotine-seeking behavior and nicotine withdrawal. Though 
there is mounting evidence suggesting the MHb is responsible for various behavioral responses to 
various drugs of abuse, the position of the MHb in regulating relapse-like behaviors remains 
tenuous. The present dissertation examined the role of the MHb in regulating reinstatement of 
cocaine-associated behavior. We demonstrate MHb activity is engaged during relapse of cocaine-
associated behavior and driving activity in a subset of the MHb population mimics the 
reinstatement response. Moreover, we identify a unique epigenetic signature at transcription factor 
Nr4a2 that is critical for the reinstatement of cocaine-associated behaviors. My studies provide 
new insight into the role of molecular adaptations within the MHb in regulating substance use 
disorders.
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Introduction 
Substance Use Disorders, Drug-Induced Adaptations, & Cocaine-Associated Memories  
Substance use disorder (SUD) is a complex chronic neuropsychiatric disease with a 
dramatic prevalence, both globally and within the United States. As of 2014, the United States is 
estimated to spend over $600 billion annually in addressing the health and societal impacts of 
substance abuse2–4. SUD has several defining features outlined in the DSM-5, hallmarked by 
progressive increases in drug-taking behavior, even in the face of adverse consequences5. Repeated 
exposure to drugs of abuse is known to cause long-lasting changes to the neural circuitry 
underlying memory, reward, and motivated behaviors. These changes are thought to provide the 
characteristic resilience and persistence of drug-seeking behavior, even following long periods of 
abstinence. Identifying the neural pathways and molecular mechanisms targeted by drugs of abuse 
has the potential to significantly alter our understanding and improve treatment of SUD.  
Drugs of abuse have been coarsely divided into various subclasses such as 
psychostimulants (e.g., cocaine, methamphetamine, nicotine, ecstasy), depressants (e.g., alcohol, 
cannabis, opiates), and hallucinogens (e.g., lysergic acid diethylamide [LSD], mescaline, 
psilocybin) based on their subjective effects. It is important to note, however, that this 
categorization does not provide sufficient insight into the functional mechanisms by which each 
drug operates. Nevertheless, while the somatic effects of each drug of abuse may vary, they all 
converge in their ability to induce dopamine (DA) release in the mesolimbic pathway; 
dopaminergic neurons of the ventral tegmental area (VTA) release DA (among other 
neurotransmitters such as GABA and glutamate) onto the medium spiny neurons (MSNs) of the 
nucleus accumbens (NAc) (among several other regions including the prefrontal cortex and dorsal 
striatum). Morphine, for example, is a potent agonist to the Gi-coupled μ-opioid receptor (MOR1), 
leading to disinhibition of VTA DA neurons, further driving DA release6. Alternatively, cocaine 
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functions primarily as an antagonist to the dopamine transporter (DAT; although it also blocks the 
serotonin and norepinephrine transporters7,8), leading to increased synaptic DA9. Due to its unique 
pharmacology, cocaine generates a specific molecular and synaptic profile throughout the central 
nervous system (CNS).  
As a result of the dense dopaminergic projection from the VTA to the NAc, the 
mesoaccumbal pathway is particularly susceptible to changes induced by acute and repeated 
cocaine exposures. Chronic cocaine has been shown to increase the expression and enzymatic 
activity of tyrosine hydroxylase (TH), the rate limiting enzyme in DA synthesis, in the VTA, while 
decreased TH enzymatic activity was measured in the NAc10,11. In addition, chronic cocaine leads 
to the accumulation of ΔFosB and Cdk5 in the NAc, believed to be a key compensatory adaptation 
to the chronic effects of cocaine administration12–14. Additionally, the accumulation of ΔFosB 
coincides with the dysregulation of several CREB-regulated genes, such as Nr4a2. In post-mortem 
tissue of human chronic cocaine users, NR4A2 is downregulated in both the VTA and ventral 
striatum15–17. Also known as NURR1, NR4A2 is a nuclear orphan receptor, whose endogenous 
ligand remains undiscovered. However, it functions as an immediate early gene (IEG) and 
transcription factor that is of particular importance to the mesolimbic DA pathway and necessary 
for DA-neuronal development18–21. Moreover, while the full range of NR4A2 gene targets is 
unknown, several genes involved in plasticity and DA signaling that are dysregulated following 
cocaine are known to be downstream of NR4A2 and include Bdnf, Cebpb, Dat , Th, and Egr122–
24. Changes to NR4A2 levels could be a byproduct of this compensatory ΔFosB in response to the 
altered DA reuptake caused by chronic cocaine exposure; NR4A2 effects on DA transmission are 
likely to be upstream of DAT, as NR4A2 is not known to interact with DAT directly. Outside of 
the mesolimbic pathway, NR4A2 is a key regulator of memory and plasticity and its importance 
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in various neurobiological processes will be periodically highlighted throughout the introduction 
to this dissertation25–28.  
Nevertheless, it is important to note that many of the cocaine-induced adaptations in gene 
expression do not occur globally throughout the mesolimbic pathway. Cocaine-mediated 
dopamine release in the NAc, simultaneously hyperpolarizes D2-receptor expressing MSNs (D2-
MSN) and depolarizes D1-receptor expressing MSNs29. This bidirectional response to dopamine 
is mediated by the opposing G-proteins in the D1- and D2-G-protein coupled receptors: D1-
receptors are Gs/a coupled while D2-receptors are Gi coupled, leading to activation or inhibition of 
PKA upon activation by dopamine, respectively29,30. As a result, long-lasting cocaine-mediated 
changes to the molecular mechanisms within the mesoaccumbal pathway, including unique gene 
induction and the upstream regulatory mechanisms, often diverge based on these cell-types. For 
example, while CREB phosphorylation (pCREB) has been shown to occur throughout the NAc in 
response to cocaine31, cocaine exposure significantly upregulates several CREB-regulated 
plasticity genes in NAc D1-MSNs including CamkIIα, Creb, Fosb, Sirt1, and Nr4a2, and 
downregulates these same genes in D2-MSNs32. One mechanism which may mediate these 
changes in plasticity and gene expression is the bidirectional phosphorylation of the 32kd-
dopamine and cAMP response protein phosphatase (DARPP-32). In response to acute cocaine, 
D1-MSNs enrich with T34-phosphorylated DARPP-32 (pT34), D2-MSNs, conversely, become 
enriched with T75-phosphorylated DARPP-3233,34. When phosphorylated at Thr34 (pT34), 
DARPP-32 potently inhibits protein phosphatase 1 (PP1) and enables cAMP-facilitated gene 
expression; however, when phosphorylated at T75 (pT75), DARPP-32 inhibits PKA signaling 
cascades35,36. Following prolonged cocaine exposure, D1-MSNs become enriched with pT75-
DARPP-32 and D2-MSNs enrich with pT34-DARPP-3237. The cell-type specific balance of 
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DARPP-32 phosphorylation is a critical mediator of cocaine-associated behaviors and its role in 
regulating gene expression will be further discussed below.  
Ultimately, these cell-type specific changes to gene expression and to the molecular 
regulators of transcription lead to changes in the mechanisms regulating associative memory, such 
as synaptic plasticity. Long-term potentiation (LTP; an in-vitro assay often described as a correlate 
to memory) and synaptic strength are increased in the VTA following various cocaine 
regimens38,39. However, increased DA signaling from the VTA causes inhibition of D2-MSNs and 
excitation of D1-MSNs. D2-MSN inhibition blunts LTP and global excitability in response to 
acute and chronic cocaine in the NAc40–43. This divergent response is necessary for the rewarding 
properties of cocaine. Alternatively, cocaine withdrawal is associated with enhanced glutamatergic 
strength in the NAc that is subsequently blunted by cocaine re-exposure43.  
All this to say, the adaptations to cocaine exposures are extensive and fundamentally alter 
the endogenous function within the VTA-NAc pathway. However, while acute activation of the 
canonical “reward circuits” (e.g. the mesolimbic dopamine pathway) plays a major role in the 
rewarding properties of drugs of abuse, activity in this pathway alone fails to encapsulate the gamut 
of phenotypes in SUD, particularly the propensity to relapse in response to drug-associated cues, 
even following long periods of abstinence. As such, researchers have focused on identifying not 
only the mechanisms within the mesolimbic pathway that are engaged during relapse, but also 
characterizing the various regions that project into and throughout the mesolimbic pathway to 
regulate the chronic relapsing nature of SUD.  
An early observation of human SUD patients is the ability of drug-associated cues to elicit 
cravings and, ultimately, relapse of drug-seeking behavior44,45. Positive hedonic state and 
rewarding properties of drugs of abuse, such as cocaine, become associated with the cues and 
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context of drug exposure. Human imaging studies have shown drug-associated cues or drug re-
exposures are able to reengage the neural circuitry activated by the initial drug experience, 
including hippocampal, prefrontal cortical, and mesolimbic brain regions44,46–49. This phenotype 
has been reproduced in various animal models of cocaine-associated behaviors, including self-
administration and conditioned place preference (CPP). For example, fast scan cyclic voltammetry 
and GCaMP mediated fiber photometry (both in vivo techniques for monitoring neuronal activity 
in near real-time) have demonstrated increased dopamine release, increased D1-MSN activity, and 
suppressed D2-MSN activity in response to cocaine predictive cues42,50 in the ventral striatum. 
Moreover, cocaine-induced CPP potentiates NAc-projecting hippocampus neurons that encode the 
cocaine-paired spatial environment51. Re-exposure to cocaine-paired cues also replicates several 
of the molecular phenotypes induced by cocaine, including increased pT34-DARPP-32 and 
pCREB in the NAc52. As with the circuit activity induced by drug-associated cues, several 
molecular signatures are regenerated in other whose signaling converges into the NAc, including 
the infra- and prelimbic prefrontal cortices, basolateral- and central amygdalae, dorsal striatum, 
and hippocampus, among many others. For example, the dorsal hippocampus shows cocaine-
paired cue-induced increases in pGluR1, pERK2, and pCREB52. It appears that these various brain 
regions respond not only to the direct pharmacological effects of cocaine, but also generate 
molecular and cellular memories for the environmental predictors of cocaine experience. 
In both human and rodent models of SUD, drug-associated cues re-illicit drug-seeking 
behavior by mimicking the neurological effects induced by the drug itself, including neural circuit 
activation. As such, work from several groups have identified a core structure of the circuitry 
mediating relapse of cocaine-seeking behavior. Specifically, both cue and cocaine-primed 
reinstatement engage glutamatergic mGluR5-dependent inputs from the prefrontal cortex (PFC), 
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hippocampus, and amygdala that converge onto ventral pallidum (VP)-projecting NAc neurons53–
57.  Nevertheless, a direct link between the specific molecular and synaptic mechanisms altered by 
drug exposure (both acute and chronic) that lead to repetitive drug use and relapse remains yet to 
be clearly established. Repeated exposure to cocaine induces changes throughout the various levels 
of neuronal function, including gene expression and synaptic plasticity. These underlying 
molecular adaptations, ultimately, cause long-lasting changes in the pathways regulating memory 
and motivation to form strong associative memories that underlie SUD. Reengagement of these 
associations subsequently re-activate these adapted circuits to drive cravings and relapse of drug-
seeking behavior.  
The author would like to note that an equally long discussion can be had characterizing the 
phenotypes of each drug of abuse, but for the sake of “brevity” discussions throughout this 
dissertation will focus primarily on the effects of cocaine and cocaine-associated behaviors. 
Moreover, the goal of this introduction is not to encapsulate the entirety of research in the SUD 
field, nor fully describe the various aspects of drug associated phenomena, but to merely 
demonstrate that the molecular adaptations throughout various neural pathways in SUD form a 
mosaic that is as complex as the behavioral phenotypes they underlie. Due to the long-lasting and 
often robust changes in gene expression and plasticity in the neural circuitry regulating SUD, 
neuroepigenetics is now being pursued to better understand the changes caused by drugs of abuse. 
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A Brief History of Epigenetics 
It is well established that targeted changes in gene expression are required for long-lasting 
forms of synaptic plasticity and long-term memory formation. Given the persistence of long-term 
changes in both gene expression and cell signaling in SUD, studies have now focused on epigenetic 
mechanisms in mediating the effects of drugs of abuse.  
Conrad Waddington coined and defined the term ‘epigenetics’ as: “the branch of biology 
which studies the causal interactions between genes and their products [proteins; i.e. transcription 
factors], which bring the phenotype into being.”58 While the mechanisms driving cellular 
differentiation are seemingly intuitive in retrospect, the goal of understanding how multi-cellular 
organisms are generated from a single template is astounding given the biological and historical 
context. During the inception of Waddington’s epigenetics (1942), the discovery of DNA’s 
structure had not yet been stolen from Rosalind Franklin (195359–61), Hershey and Chase had not 
yet officially confirmed DNA as the hereditary unit of information across cellular generations 
(195262), and the first transcription factor had yet to be identified (197863; the author would like to 
note that the discovery of the first transcription factor coincided closer in time with the revelation 
of Darth Vader being Luke Skywalker’s father than with Waddington’s hypothetical epigenetic 
regulation64).Yet, somehow Waddington understood there must be underlying mechanisms with 
which cells are able to generate a cell fate and that this supergenetic programming could be carried 
in a heritable fashion.  
Epigenetics, as a field, has had a major influence throughout biology; it would be an easier 
task to list the branches of biology without a major epigenetic component than to list those that do. 
Nevertheless, although epigenetics has traditionally focused on the determining of cell fate, the 
term has evolved alongside biology’s understanding of the underlying mechanisms driving genetic 
regulation. Currently, epigenetics generally refers to the study of changes in gene expression 
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independent from changes in the DNA sequence itself. DNA is organized into nucleosomes- 
repeating units of 147 base pairs of DNA spooled around a histone octamer65. Typically, epigenetic 
machinery regulates transcription by altering the structure of nucleosomes and, ultimately, access 
to genomic DNA. Epigenetic modifiers do so through four major families of modifications: 1) 
DNA methylation, 2) nucleosome remodeling (the sliding of nucleosomes by large super-
complexes called nucleosome remodeling complexes) 3) several RNA mechanisms, and 4) histone 
modifications (also referred to as chromatin modifications, and incorrectly referred to as chromatin 
remodeling)66–73. Although all four modifications have critical roles in the regulation of gene 
expression, post-translational modifications to histone tails are by far the most extensively studied 
in the field of neuroepigenetics and will be the focus of this dissertation. 
The histone octamer is composed of four essential histone proteins, H2A, H2B, H3, and 
H4, each with variants that can be exchanged and each with positively charged N-terminal tails 
that interact tightly with the negatively charged DNA backbone. It is this interaction between the 
histone tail and spooled DNA that is sensitive to the covalent post-translational modifications that 
are present on the histone tail65. The list of post-translational modifications is extensive (and 
includes but is not limited to acetylation, phosphorylation, ubiquitination, methylation, 
dopaminylation, and serotinylation); each is governed by a unique set of enzymes and each 
modification uniquely alters chromatin state and DNA accessibility65,74,75. For example, histone 
acetylation is generally considered a mark permissive for gene expression as the addition of a 
negatively charged acetyl group to the positively charged histone tail allows for the relaxation of 
chromatin structure and loosens spooled DNA. Two major classes of enzymes have a critical role 
in modifying histone acetylation in an activity-dependent manner: histone deacetylases (HDACs) 
and histone acetyltransferases (HATs). The known HDACs are subdivided into four classes based 
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on shared families of protein domains; the most commonly studied are the Class I HDACs 
(HDACs -1, -2, -3, & -8) and Class 2 HDACs (HDACs -4, -5, -6, -7, & -9)76. The HAT families, 
on the other hand, are far more extensive, with CREB Binding Protein (CBP)/p300 and GCN5 
being the most commonly studied77. Both HDACs and HATs operate in concert with other 
transcriptional repressors and activators, respectively. For example, HDAC3 is known to form a 
complex with HDAC4, HDAC5, N-COR, and SMRT. Because HDACs do not in and of 
themselves have bromodomains (domains that read the current acetylation state of a histone tail) 
or DNA-binding domains, targeting of deacetylase activity depends upon on its interaction with 
N-COR and SMRT78,79. HATs, too, form large complexes of transcriptional activators. As its name 
implies, CBP is a protein that binds CREB and, in conjunction with other transactivators, is able 
to target particular gene loci77,80. HDAC activity typically leads to a more compressed chromatin 
structure generally associated with gene silencing (due to removal of histone acetyl groups and 
strengthening of the positive tail/negative DNA interaction). Conversely, HATs add acetyl groups 
to histone tails and their activity typically leads to a more relaxed chromatin structure generally 
associated with gene activation. Due to this interaction, HDACs are believed to serve as a 
molecular brake pad, repressing gene expression until disengaged by an activity-dependent event 
permitting HAT-mediated gene expression. 
In addition to directly competing for real estate in the histone code, histone modifications 
function in a combinatorial fashion. For example, phosphorylation of Histone 3 Serine 10 
(pH3S10) not only prevents methylation from occurring at the same site, but also serves as a 
docking point for HATs, such as KAT2A; thus, pH3S10 preferentially leads to KAT2A-mediated 
acetylation at H3K9, H3K14, and H3K27 (and, again, preventing methylation to occur at these 
same residues81–84). This process, known as phosphoacetylation, is critical throughout 
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development85 and recent work suggests a role for phosphoacetylation in the gene expression 
necessary for memory formation and drug-associated behaviors and will be further discussed 
later85–87. Moreover, not only do interactions within a single family of histone modifications occur, 
but these interactions are known to occur across families of epigenetic mechanisms as well. As a 
brief example, proteins within the neuronal Brg1/hBrm-Associated Factor (nBAF) nucleosome 
remodeling complex contain histone-reading bromodomains. These bromodomains read the 
histone-modification state and alter large scale chromatin structure, providing another layer of 
DNA accessibility and gene regulation66. Also, while RNA products, such as long non-coders and 
microRNAs, have been known to disrupt gene expression (one of many violations to the 
fundamental dogma of biology discovered by epigeneticists), recent work has demonstrated that 
RNAs directly interact with, and alter the function of epigenetic writers; enhancer RNA (eRNA) 
binding to CBP activates CBP-mediated histone acetylation and gene expression in a targeted 
manner88. All this to say that while the field of epigenetics has made critical advances (and often 
revisions) to our understanding of the neuron, there exists a far more complex story than the early 
work describing HDAC:HAT interactions. 
The collection of covalent modifications and altered chromatin structure provide a signal 
integration platform that guides transcriptional protein complexes to ultimately regulate specific 
gene expression profiles. As Waddington predicted, the collection of these epigenetic mechanisms 
is causal in targeted transcription. Epigenetic modifiers function as the heritable programming for 
cellular development and differentiation. As such, their role in transforming stem cell to cell fate 
has been well established. Yet, do these epigenetic modifiers continue to function once cell fate is 
established? What is their function in a post-mitotic cell population, such as neurons? Discoveries 
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in the learning and memory field have recognized the retrofitting of these epigenetic modifications 
in controlling the gene expression required for neuronal plasticity.   
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Epigenetics in Learning & Memory 
 The generation of plasticity and long-term memory is known to require a complex cascade 
of molecular and cellular adaptations in response to stimuli, including (but not limited to) NMDA 
receptor activation, Ca2+ influx, protein kinase cascades, and CREB phosphorylation. However, 
one common feature of these adaptations is their convergence on generating activity-dependent 
gene expression. One of the earliest demonstrations that gene expression is required for long-term 
memory formation came from using transcription-specific blockers following training in 
goldfish89–91. Transcription dependence of long-term memory formation has subsequently been 
demonstrated to be well conserved across species, from fish to crustaceans to rodents to primates. 
Since this early work, the role of activity-dependent expression of IEGs and related transcription 
factors in learning processes has been extensively discussed, studied, reviewed, characterized, 
detailed, and evaluated elsewhere and will not be a major focus of this discussion. However, the 
epigenetic regulation of IEGs and their products (aligning with Waddington’s original definition 
of epigenetics) during learning events has been rediscovered and provides a beachhead for 
understanding the role of the epigenome in memory processes. The earliest evidence that the 
epigenome in adult neurons responds to learning events came in 1979. Schmitt and Matthies 
demonstrated a training event can induce histone acetylation in the hippocampus92. Shockingly, it 
took nearly three decades for the role of histone modifications in learning to be rediscovered as 
several groups, nearly simultaneously, demonstrated targeted task and region-specific histone 
modifications93–96. As a direct result, these changes to histone state were discovered to be a 
necessary component for the gene expression required in long-term memory formation and have 
become a major focus of neuroepigenetics since74,86,95,97–99.  
HATs and HDACs, the enzymes regulating histone acetylation, are one of many key 
activity-dependent epigenetic modifiers. And, since the rediscovery of learning-dependent histone 
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acetylation, memory researchers have focused on HAT and HDAC families as modulators of 
memory. Various forms of HAT inhibition have been shown to impair associative processes that 
rely on activity-dependent gene expression. Mice with conditional CaMKIIα-driven deletion of 
Kat2a (HAT formerly known as Gcn5) show deficits in hippocampal LTP100. Similarly, loss of 
CBP function in the hippocampus disrupts the maintenance of LTP101,102. As is often the case 
(though not always) these deficits in LTP are also reflected in failures in long-term memory 
formation. KAT2A KO animals show deficits in hippocampus-dependent memory formation, 
aligning with the loss in LTP100. Loss of CBP activity in the dorsal hippocampus also generates 
memory impairments in various hippocampal tasks including contextual fear conditioning, 
inhibitory avoidance, novel object recognition, and the Morris water maze; when disrupted in the 
amygdala complex, animals display deficits in the acquisition of cued fear conditioning93,101–108. 
Similar memory deficits were seen in transgenic mice with loss of HATs p300 or PCAF 
function109,110. Consistent with this, pharmacological inhibition of class I HDACs (which includes 
HDAC3) and genetic deletion of HDAC3 not only generate enhancements to LTP but also generate 
profound enhancements to memory formation in various tasks, including novel object recognition, 
fear learning, and Morris water maze94,108,111–116. Work from the Wood lab has demonstrated that 
it is the loss of deacetylase function (not necessarily disruption of any HDAC3-containing 
complex) mediating these memory enhancements. A histidine point mutation at tyrosine 298 
(Y298H) generates a deacetylase dead dominant-negative HDAC3117; overexpression in the dorsal 
hippocampus blocks memory formation in the object location task and contextual fear, while 
overexpression in the amygdala blocks formation of cued fear118. These series of experiments 
provide evidence for epigenetic modifiers as powerful regulators of plasticity and plasticity, but 
also raise the question of how HATs and HDACs interact to regulate memory formation. 
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Loss of CBP and HDAC3 function impairs and enhances memory, respectively, through 
changes in the histone acetylation state and subsequent gene expression. The molecular brake pad 
hypothesis posits that HDACs and their associated complexes function as transcriptional 
repressors, preventing acetylation and subsequent gene expression until sufficient stimulation 
disengages these repressive complexes. Indeed, CBP deletion in the hippocampus blunts 
acetylation of known CBP histone targets, H4K8, H2BK12, and H3K1465,102. Moreover, loss of 
CBP prevents the induction of training-induced histone acetylation at several IEGs, including 
FosB, Bdnf, Zif268, Cebp, Nfkb, and Nr4a2. This gene-specific loss of histone acetylation 
correlates with decreased activity-dependent expression at these same target genes93,95,102,119,120. 
Conversely, manipulations that generate an HDAC3 loss of function (including genetic deletion, 
pharmacological inhibition, and dominant-negative over-expression) enable hyperacetylation 
throughout several H3 and H4 residues. As with CBP deletion, these changes in acetylation are 
targeted to, and correlate, with training-induced increases in IEGs necessary for learning and 
memory including Bdnf, Nr4a1, cfos, and Nr4a294,108,112,115,118. Unsurprisingly, HDAC3 and CBP 
appear to compete for epigenetic antagonistic influence at the same histone residues and gene loci. 
Even though there are vast global changes to histone state following CBP:HDAC3 
deletions, of particular note are the changes that occur at the promoter of Nr4a2. Learning events 
(such as training in water maze, conditioned fear, or object location) disengage HDAC3 from the 
Nr4a2 promoter, recruit HATs (such as CBP) to acetylate the same loci, and drive Nr4a2 gene 
expression25,26,118,121. As previously described, HDAC3 disruption can artificially generate 
enhancements to learning by generating a permissive transcriptional environment. However, these 
memory enhancements are dependent on acetylation at the Nr4a2 promoter and subsequent 
increase in Nr4a2 expression. Several studies have shown HDAC3 functions as a break pad on 
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memory through its negative regulation of Nr4a2 where loss of HDAC3 fails to generate memory 
enhancements when Nr4a2 is knocked down simultaneously27,112,121. This unique relationship 
between HDAC3 and Nr4a2 will be further explored throughout this dissertation. 
Although this dissertation will focus on the role of histone acetylation in regulation of gene 
expression and neuronal function, other families of epigenetic mechanisms play key roles in adult 
cognition. For example, Vogel-Ciernia et al. have demonstrated that a neuron-speciic subunit 
BAF53B, within the nucleosome remodeling complex nBAF is necessary for long-term 
memory122. Disruption of BAF53B (either in mice with heterozygous deletion of Baf53b or 
transgenic overexpression of a dominant-negative splice variant) leads to deficits in LTP in the 
hippocampus and loss of hippocampal long-term memory formation in object location and 
contextual fear conditioning tasks. These memory impairments can be restored with 
overexpression of wild-type BAF53B122,123. Surprisingly, recent work has demonstrated that 
deletion of HDAC3 in the dorsal hippocampus is also able to restore synaptic plasticity and spatial 
memory in animals with BAF53B disruption124, providing further evidence for the combinatorial 
nature of these molecular mechanisms. 
The above is not meant to serve as an exhaustive review of the role of epigenetic 
mechanisms in learning and memory, but merely to provide examples of how epigenetic modifiers 
(particularly HDAC3 and competing HATs) are able to confer changes to histone state, gene 
expression, associative processes, and, ultimately, behavior. Specifically, HDAC3 inhibition 
disengages the molecular brake pad allowing for HAT-mediated acetylation and generation of a 
more permissive environment for the gene expression necessary for long-term memory formation. 
Conversely, inhibition of HATs (such as CBP) leads to a more compressed chromatin structure 
that inhibits the gene expression necessary for memory formation. There are various HDACs and 
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HATs that operate independently and concurrently with each other, HDAC3 and CBP are merely 
two canonical examples. It is important to be aware that this is a simplistic description of the key 
mechanisms regulating transcription; changes to histone state are permissive, but not instructive 
to the molecular cascades culminating in the gene expression required for learning and memory. 
For example, simultaneous deletion of HDAC3 and CBP is unable to generate the memory 
enhancements seen with HDAC3 deletions alone, demonstrating that loss of deacetylase activity 
is insufficient to recruit the totality of transcriptional machinery113. However, these epigenetic 
mechanisms have now been established as upstream regulators of the gene expression needed for 
synaptic plasticity. Researchers in the learning and memory field have shown that these enzymes 
are powerful regulators of memory formation and associative processes which can be artificially 
manipulated to either block or enhance memory. Given the long-lasting nature of the changes seen 
in SUD (particularly in mechanisms regulating gene expression and plasticity), are drugs of abuse 
able to tap into these epigenetic mechanisms to provide the resilience of drug-seeking behavior?  
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Epigenetic Regulation of Reward Circuitry and Response to Drugs of Abuse 
 Drugs of abuse cause long-lasting changes in plasticity and behavior. Due to the enduring 
nature of these changes, addiction researchers have hypothesized that epigenetic machinery is 
engaged to drive the neural circuitry changes seen in SUD. Indeed, several groups have 
characterized the epigenetic response to both acute and chronic drug exposures. While no single 
drug or drug class is unique in its ability to alter the epigenome, each generates a unique signature 
across the epigenome and neural circuitry underlying motivated behaviors. Similar to the 
neuroepigenetics of learning and memory, the epigenetic adaptations seen in response to the 
various drugs of abuse also accumulate in a targeted fashion. For example, adolescent rats 
chronically treated with ethanol show dramatic increases in H3 and H4 acetylation at Fosb, cFos, 
and Cdk5, whereas adult-treated animals show a hypermethylation in the prefrontal cortex and 
dysregulation at several genes involved in neurotransmission including Syt2125,126. Conversely, 
opioids (such as heroin and morphine) enrich the striatum with repressive histone methylation and 
blunt permissive histone acetylation, particularly at the promoters of Bdnf and Nr4a2127. The 
observed changes to histone methylation have been observed through withdrawal and appear to 
mediate the incubatory effects on heroin seeking. These results highlight the long-lasting effects 
of these epigenetic changes and the subsequent influence on behavior.  
Regarding epigenetic effects of cocaine use disorder, there is an abundance of research on 
the adaptations within the striatum81,128–131. Several studies have shown the accumulation of 
permissive histone marks in NAc D1-MSNs in response to both acute cocaine and cocaine re-
exposures, including pH3, H3K14Ac, H3K18Ac, H4K5Ac, H4K8Ac, H3K12Ac and the 
combinatorial phosphoacetylation at H3S10/K14; these histone marks are enriched at the 
promoters of various genes involved in NAc plasticity, including Fosb, cFos, Cdk5, Bdnf, Nr4a2 
and correlate with their increased expression12,87,132–135. However, although both acute and cocaine 
18 
 
re-exposures induce several phosphoacetyl marks in D1-MSNs, the accumulation occurs 
significantly more in acute treatments compared to re-exposed animals. Recent work identifying 
unique transcription profiles during cocaine re-exposures vs. acute cocaine136 would suggest that 
this is not necessarily a blunted response to cocaine re-exposure, but a selective recruitment of 
these epigenetic mechanisms to novel gene targets. Similarly, chronic cocaine induces various 
changes in histone modifications overlapping with those seen in acute cocaine, such as increases 
in H3K9me3 and H4K5Ac133. Due to the significant non-overlapping nature it is more likely that 
chronic cocaine exposure is generating an epigenetic environment unto itself137–139 than a 
degradation of the environment generated by acute cocaine.  
 These drastic changes have further led researchers to study the impact of cocaine on the 
various enzymes that are known upstream regulators of these modifications to the histone code. 
The observed increase in phosphoacetylation is likely mediated by the convergence of pMSK1, 
pERK, and P-Thr34-DARPP-32 as these post-translational modifications accumulate in the 
nucleus of D1-MSN following acute cocaine, catalyze H3 phosphorylation, and simultaneously 
protect pH3 through inhibition of PP134,134,140. Both acute and chronic cocaine also target more 
canonical epigenetic enzymes, such as HDACs and HATs. Cocaine exposure results in the 
recruitment of CBP to the Fosb and Nr4a2 promoters, correlating with the described increases in 
loci-specific histone acetylation and gene expression132,141, and induce the nuclear export and gene-
specific disengagement of HDACs 3 and 5135,142. To be clear, this is only a sampling of the various 
resulting effects drugs of abuse have on the epigenome (the full extent of epigenetics research in 
SUD has been reviewed extensively elsewhere), it is clear drugs of abuse profoundly alter the 
epigenome, often, in concert with the previously discovered mechanisms necessary for the 
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addictive phenotype. Researchers now look to reverse these drug-induced changes to the 
epigenome as a means of reversing long-lasting drug-associated behaviors.  
 Since drugs of abuse, in particular cocaine, are able to affect endogenous epigenetic 
function, several studies have targeted epigenetic regulating enzymes. As in the learning and 
memory field, studies focusing on the upstream regulators of histone acetylation have 
demonstrated that HATs and HDACs appear to be positive and negative regulators, respectively, 
of cocaine-associated behaviors. Overexpression of HDACs (such as HDAC4 and -5) or loss of 
HAT function (such as CBP) prevent cocaine-induced CPP and changes in cocaine-induced gene 
expression, particularly at Nr4a212,132,141–143. Conversely, Class 1 HDAC inhibition or deletion 
(including HDAC3) enhances cocaine-associated behavior, including sensitization and 
CPP12,135,141. Most of this work has centered on balancing HAT and HDAC activity, although 
studies have also characterized the role of nucleosome remodeling in cocaine-associated 
behaviors. Animals with loss of function mutations to BAF53B show deficits in cocaine-induced 
CPP and LTP that is restored with targeted overexpression of Bdnf to the NAc144. Baz1a, a member 
of the ISWI nucleosome remodelers, is induced by acute cocaine and, when overexpressed in the 
NAc, blocks cocaine-induced CPP145. This body of work demonstrates that drugs of abuse tap into 
the endogenous molecular machinery, in particular the machinery that provides epigenetic 
regulation to gene expression, and researchers are able to likewise able to tap into these 
mechanisms to reverse the effects of drugs of abuse. The advent of CRISPR-dCas9 will allow for 
gene loci-specific targeting of epigenetic modifications to provide further specificity to these 
manipulations and identify drug-induced changes susceptible to future therapeutics. 
The growing field of addiction epigenetics has fundamentally changed our understanding 
of SUD. It has provided further evidence of SUD being a neurobiological disease, not a behavioral 
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flaw in individuals lacking will power. However, it has also provided a stronger understanding of 
the biological mechanisms that drugs of abuse recruit and modify, often in a combinatorial fashion 
(often referred to as the gateway hypothesis). While the ideas that cannabis provides the only path 
to SUD or use of a legal drug is a prerequisite for subsequent dependence to an illicit drug are 
completely absurd (and travel with a rather large suitcase of racial bigotry), there is accumulating 
evidence that long term exposure to one drug of abuse can leave individuals susceptible to the 
subsequent neurobiological effects of others, via both epigenetic and non-epigenetic mechanisms. 
For example, nicotine and alcohol pretreatment enhances subsequent cocaine-induced CPP and 
self-administration, respectively. In the case of nicotine, this enhancement to cocaine associated 
behavior is likely mediated by nicotine’s ability to increase H3/H4 acetylation through degradation 
of HDAC4/5 and enhance LTP in the amygdala and NAc41,146,147. Moreover, early life cannabis 
exposure generates long lasting changes in histone methylation throughout the striatum, leading to 
increased sensitivity to rewarding properties of opioids (such as heroin)148–150. These cannabis-
induced effects on opioid sensitivity have (alarmingly) been shown to be transferred across 
generations, as offspring of cannabis exposed animals have increased neurobiological responses 
to acute heroin exposure151,152. Each drug of abuse creates a unique epigenetic signature and these 
changes to the epigenome are what leave the neural circuitry susceptible to the effects of other 
substances. 
Still, the bulk of the neuroepigenetics research has focused on the core circuitry known to 
regulate reward, motivation, and learning (such as the PFC, NAc, dorsal striatum, and VTA). In 
the same fashion that no single Deathly Hallow makes one the Master of Death, no single brain 
region, neural circuit, cell-type, receptor, kinase, or transcription factor is likely to provide the cure 
to SUD. It will take a nearly complete understanding of drug-induced dysfunctions to yield a path 
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towards comprehensive therapeutics, neither of which neuroscientists currently wield. While there 
are volumes of research investigating the mechanisms and effects of cocaine exposure, the field 
unfortunately has not yet generated an effective therapeutic for cocaine use disorder. As such, it is 
critical that as the field continues its depth of understanding in these aforementioned brain regions, 
it also expands its breadth to include the other neural pathways critical to the drug response 
including the raphe nuclei, ventral pallidum, and habenula. 
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Structure and Function of the Medial Habenula 
Circuitry and Organization 
The habenula is an evolutionarily conserved epithalamic complex present from zebrafish 
to primates. In zebrafish, the habenula complex is made up of dorsal and ventral subregions; the 
mammalian correlates of these substructures are the medial (MHb) and lateral (LHb) habenula, 
respectively153. Of these substructures, disproportionate research has focused on understanding 
LHb function and circuitry. Recent work has characterized the LHb as a reward prediction error 
locus. LHb glutamatergic projections to the GABAergic rostral medial tegmental grey (RMTg) 
generate inhibition of VTA DA neurons and serve as a signal for aversive (or, more accurately, 
reward-omitted) states154. As such, its role in regulating motivated behaviors has become clearer 
over recent decades. On the other hand, the MHb has been relatively neglected by the majority of 
neuroscience and is often excluded from even the most inclusive addiction-related diagrams. One 
of the earliest descriptions of the MHb came from Santiago Ramón y Cajal in 1911. Ramón y Cajal 
provided detailed drawings of the dense input of the stria medullaris to the MHb and the dense 
output to the interpeduncular nucleus (IPN) via the fasciculus retroflexus (See Fig. 0.1)155. The 
MHb, however, was neglected for the better half of the 20th century despite this pioneering work.  
Renewed interest in the habenula complex has continued Ramón y Cajal’s early work in 
attempts to provide a definitive function for this small evolutionarily conserved region. With the 
advent of advanced genetic and tracing techniques, the internal structure and cellular properties of 
the MHb are now better known despite its small size (in humans, the complete habenula complex 
is ~30mm3, about the size of a grain of rice156,157). It is important to note that within the gross 
organization of the MHb exists a more refined subcircuitry in the MHb-IPN pathway. Five major 
substructures have been identified within the MHb: Superior, Intermediate, Central, Medial and 
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1Lateral nuclei. Nevertheless, the MHb most commonly is divided into Substance P-rich dorsal 
(dM Hb) and cholinergic ventral (vMHb) subregions, both of which co-release glutamate158. 
Although superficial, this first-level organization is convenient, functionally relevant, and will be 
further explored and employed throughout this dissertation.  
Primary MHb inputs from the medial septum (triangular nucleus) and the diagonal band of 
Broca converge via the stria medullaris and are comprised of various neurotransmitters such as 
glutamate, ATP, acetylcholine, and, of particular interest, an excitatory GABAergic input (the 
MHb has low levels of KCC2, the transporter responsible for generating a low intracellular [Cl-]; 
as a result, the activation of GABAA receptors causes Cl- efflux and subsequent depolarization)159. 
The balance of these varying inputs provides the tonic baseline firing rate (~4Hz) seen in both the 
                                                     
1 Adapted from 155 
Figure 0.1: Ramon y Cajal drawing of the epithalamus. Sketch includes one of the first 
descriptions of the (D) MHb and its projection to the (E) IPN via the (d) fasciculus retroflexus 
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dMHb and vMHb159–162. Moreover, a dense serotonergic input to the MHb of unknown origin has 
been described163. Common sense would suggest that this serotonergic input originates from either 
the dorsal raphe (DRN) or median raphe nuclei (MRN), but recent tracing studies have negated 
this possibility163. Although the median raphe has been shown to project to the MHb, this 
projection is likely GABA-ergic164. One potential, yet unverified, source of this serotonergic input 
is the serotonergic population of IPN165, which likely receive direct innervation from the 
cholinergic neurons of the vMHb.  
Nevertheless, these signals converge on the MHb where projections diverge via the internal 
portion of the fasciculus retroflexus, sending the vast majority of axons to the IPN. The subregion 
projections from the MHb to the subregions of the IPN have been shown to be non-overlapping: 
the dMHb sends outputs to the lateral subnucleus (IPL), whereas the vMHb sends outputs to the 
rostral, caudal, intermediate and dorsolateral subnuclei of the IPN (IPR, IPC, IPI, and IPDL, 
respectively). Furthermore, recent circuit tracing experiments identified the targets of dMHb- and 
vMHb-innervated IPN neurons. vMHb-innervated IPN neurons (mainly IPR and IPC) send 
GABAergic projections to the median raphe and dorsal raphe nuclei164,166. As such, the MHb 
functions as a potential brake pad to serotonergic signaling167. In addition, studies using early 
tracing techniques identified sparse projections from the MHb to the LHb, VTA, and MRN, among 
others, but have not been extensively characterized or studied compared to the MHb-IPN 
pathway168. Due to the positioning of this circuitry, the MHb is considered a key hub in the dorsal 
diencephalic pathway linking forebrain and midbrain circuitry, providing an alternate to the 
median forebrain bundle. The characterization of this circuitry provides the foundation for 
understanding the systems level effects of MHb function and, ultimately, its contributions to 
behavioral outcomes. 
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Role in Behavior 
Even though evolutionarily conserved across vertebrate species, the totality of MHb 
functions are not well understood. The heterogeneous cellular organization within the MHb is 
incredibly intricate despite its small size. Several groups have sought to fully describe the unique 
transcriptome within the habenula complex169,170. Doing so may provide further insight into not 
only how the MHb generates behavioral outcomes, but also provide an avenue for targeted 
therapeutics. The vMHb has a perplexing (and often frustrating) gene expression profile which 
makes conceptualizing its function difficult. A cursory glance at the MHb transcriptome would 
lead one to believe MHb neurons occupy a pivotal space in the mesolimbic DA pathway; for 
example, the vMHb is enriched with DARPP-32171,172 (often inaccurately described as a marker 
for medium-spiny neurons); rich in Th, but lacking tyrosine hydroxylase protein, and rich in 
NR4A2173. In addition, the vMHb is also enriched with various serotonin receptors (Htr3a, Htr4, 
Htr5a, and Htr5b170,174–176) coinciding with the dense serotonergic innervation, is one of the few 
regions in the CNS expressing the kisspeptin1 receptor177,178, and, most often studied, the vMHb-
IPN pathway has the densest expression of nicotinic acetylcholine receptors (nAChRs; 
specifically, the α3-β4-α5 cluster)169,179,180. These unique properties of the vMHb provide a unique 
challenge in understanding its function, but the field at large has now dedicated significant 
attention to this goal.  
From a systems level perspective, it is important to note that various regions of the CNS 
have dichotomous structures which function in parallel, albeit often opposing, fashion; for 
example, pre-limbic vs infralimbic prefrontal cortex, NAc core vs. NAc shell, and dorsal lateral 
vs. dorsal medial striatum, all have roles in overlapping behaviors, yet often compete for 
generating behavioral outcomes. Similarly, the LHb provides feed-forward inhibition of VTA DA 
neurons (through excitation of the GABA-rich RMTg) and the MHb seems to provide feed-
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forward inhibition of the raphe nuclei (through excitation of the GABA-rich IPN). These tripartite 
pathways do receive external innervation to modulate their overall function and MHb/LHb 
function are not so easily distinguished. Nevertheless, the habenula complex appears to fit this 
dichotomous mold and this perspective can provide a framework for identifying habenula function.  
In Adaptive Responses to Aversive States 
The LHb has had significant research dedicated to describing its function. Work from 
various groups has developed a sophisticated understanding of the LHb’s influence over the 
mesolimbic DA system; the LHb receives input from the lateral septum, basal ganglia, and the 
accumbens and primarily inhibits dopaminergic release through activation of the GABAergic 
RMTg181,182. LHb activity has been shown to increase when animals are exposed to a cue-
predictive reward, but the reward is withheld. Conversely, inputs from the pallidum suppress LHb 
firing in response to reward-predictive cues183–185. LHb activity is also induced by onset of 
punishment and, when stimulated, LHb functions to generate behavioral avoidance 
phenotypes154,186. Activity in the LHb can be regulated in a biphasic manner, activity suppressed 
with the onset of reward (or reward-predictive cues) and upregulated in response to reward-
withholding or punishment onset.  
More recently, LHb dysfunction has been implicated in the onset of depressive-like 
phenotypes. In rodent models of depression (e.g.; learned helplessness), there is a loss of LHb 
volume (accounted for by a loss in glial cell count), increased glutamatergic synaptic input, and 
increased LHb metabolic activity that, as the circuitry would predict, inversely correlates with 
metabolic activity in the VTA187–189. Furthermore, this tonic increase in LHb activity has been 
linked causally to the onset and progression of depressive phenotypes. Lesions of either the Hb 
complex (which include both the MHb and LHb; a caveat which will be further discussed below) 
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or the LHb alone prevent the induction of learned helplessness (measured by latency to escape a 
shock-paired chamber), forced swim test, and tail suspension test190,191. Electrical (via deep brain 
stimulation) and pharmacological inhibition of the LHb has also been shown to improve measures 
of learned helplessness192,193. In humans, functional imaging has shown Hb dysfunction in patients 
with major depressive disorder (MDD); MDD patients are known to have increased activity in the 
Hb complex and inhibition of the LHb via deep brain stimulation can successfully alleviate 
depressive symptoms in patients of therapeutic-resistant MDD156,157,194,195. Due to this volume of 
work, the habenula complex is characterized as an aversive, anti-reward structure. But, it remains 
unclear if the MHb serves a role redundant to the LHb in regulating aversive and depressive-like 
states.  
As seen in the LHb, animal models of MDD show decreased MHb neuronal volume, but 
increased baseline activity (which as the circuitry would predict, is positively correlated with 
increased IPN activity)187,188,196. However, more recent work suggests that the MHb is responding 
to conditioned stressors, not necessarily exposure to acute stressors themselves. The MHb is 
activated during the consolidation of cued fear conditioning and has been shown to increase 
expression of various IEGs (including Nr4a2) in the vMHb. However, this vMHb engagement was 
not seen in animals that received unpaired shocks in a familiar context197, suggesting that aversive 
stimuli alone are unable to engage the vMHb. Further, lesions of the zebrafish dorsal habenula 
(analogous to the mammalian MHb) cause increased freezing to conditioned stressors, increased 
anxiety-like behaviors, and prevent the induction of avoidance behaviors177,198,199. The cholinergic 
vMHb population seem to be responsible for these adaptive responses, as functional inhibition of 
vMHb cholinergic neurons blocks the acquisition of fear extinction, whereas optogenetic 
stimulation of this same region accelerates extinction200.  Lastly, chronic stress causes a decrease 
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in various markers critical to vMHb cholinergic signaling, including Chat, vAcht, Cht, Chrna3, 
Chrnb3, and Chrnb4167. Loss of cholinergic signaling from the vMHb has been linked to 
anhedonia-like behaviors; knockdown of vMHb Chat induces a decrease in sucrose consumption 
that is resistant to the anti-depressant effects of fluoxetine. This hypocholinergic phenotype is 
reflected in suicide victims with comorbid MDD, as MHb samples collected post-mortem show 
decreased expression of various genes associated with cholinergic signaling, including significant 
decreases to CHT and CHRNB3 and trending decreases in CHAT, CHRNB4, CHRNA3 
expression167. In light of this body of work, it seems less likely that the MHb is causal to a learned 
helplessness/depressive phenotype than responsible for generating an adaptive responsive to it.   
While activity in the MHb has a clear role in generating adaptive behaviors, the upstream 
regulation of the MHb and the downstream effects of Hb activity are less understood. Ablation of 
the triangular septal cholinergic input to the vMHb and optogenetic activation of the glutamatergic 
posterior septal input to the vMHb both have been shown to be anxiolytic201,202 (the role of 
nicotine, acetylcholine, and nAChRs in habenula-mediated anxiety will be further discussed 
below). Although both inputs presumably lead to increased MHb activity, the cholinergic inputs 
from the triangular septal nucleus appear to be anxiogenic, while the glutamatergic inputs from the 
posterior septum anxiolytic. With regard to the downstream targets of MHb, there is conflicting 
evidence of the impact MHb activity may have; changes in activity in the LHb-RMTg-VTA and 
vMHb-IPN pathways often correlate as predicted, yet the downstream effects of activity in Hb 
pathways is unclear. More specifically, aside from the feedforward inhibition of VTA DA neurons 
by the LHb, what other neural circuitry does the Hb complex affect to generate these behavioral 
outcomes? Given the work implicating serotonin in anxiety and depressive phenotypes203–206 and 
the recent circuit tracing linking the vMHb to the DRN and MRN164,166, the Hb likely functions 
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through regulation of DRN and MRN serotonin. Indeed, in animals with Hb lesions, there is a loss 
of stress induced serotonin signaling in the DRN207 and, when activated, vMHb cholinergic 
neurons have been shown to inhibit DRN serotonin turn over167. Furthermore, LHb activity has 
been shown to both negatively190,208 and positively207 regulate serotonergic outputs of the DRN. 
This contradictory effect of the LHb is likely mediated by the LHb direct inputs to the DRN and 
indirect inputs to the DRN through the GABAergic RMTg. Yet, a causal link between the MHb 
regulation of DRN/MRN and adaptive responses to stress and aversion remain missing. 
The conflicting behavioral and pharmacological evidence would suggest that the role of 
the MHb is more complex than the characterization as an aversive brain region. Both gain and loss 
of function studies in the vMHb often overlook the importance of the tonic firing of the MHb, the 
transmitter systems engaged and, subsequently, being employed by the MHb; preventing induction 
of MHb activity (maintaining tonic firing) is likely to have unique behavioral outcomes than a total 
loss of MHb activity. As such, complete functional characterization and an understanding of the 
endogenous function of the MHb will likely rely on subcircuit specific, real-time, reversible 
manipulations. Nevertheless, due to its position in regulating serotonergic and dopaminergic 
circuitry in addition to its unique transcriptome, researchers have looked to the MHb as a target 
for drugs of abuse. 
In Substance Use Disorder: Nicotine 
 The unique transcriptome of the MHb can provide incredible insight into its role in SUD. 
The MHb-IPN pathway has the densest expression of nAChRs and of note are the uncommon α5 
and β4209,210. As such, nicotine researchers have targeted the MHb-IPN circuit and demonstrated 
that it as a significant regulator of nicotine-associated behaviors. Pharmacological antagonists of 
the β4-containing nAChRs within the MHb blocks nicotine-induced CPP, self-administration, and 
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nicotine-induced dopamine release in the VTA209,211–213. β4 KO animals show similar deficits in 
nicotine self-administration and nicotine-induced dopamine release that is partially restored with 
viral-mediated restoration of MHb-β4 expression214. However, this is not to say that the MHb 
solely regulates the reinforcing properties of nicotine. Studies focusing on the role of the α5 subunit 
provide contrasting evidence for how the MHb regulates nicotine-associated behaviors. Animals 
with α5 KO in the MHb show significant increases in nicotine self-administration, even at doses 
that are known to generate nicotine aversion215. This effect is reversed when α5 expression is 
restored in the cholinergic neurons of the MHb, demonstrating that α5-mediated signaling in the 
MHb facilitates nicotine aversion and functions as a clamp on nicotine consumption215. The MHb, 
however, not only regulates the acute response to nicotine intake, but also modulates the 
adaptations to long-term nicotine treatment. 
Chronic nicotine exposure generates long-lasting adaptations within the vMHb. For 
example, nicotine withdrawal sensitizes the cholinergic neurons of the vMHb to subsequent 
nicotine re-exposures216. As with the acute response to nicotine, nicotine withdrawal is dependent 
on vMHb nAChR activity. Chronically nicotine treated α5-KO animals are resistant to precipitated 
somatic withdrawal symptoms210. Perplexingly, while nAChRs of the vMHb are clearly necessary 
for the somatic expression of nicotine withdrawal, experimentally, these symptoms are often 
precipitated with mecamylamine, a nonspecific antagonist to various nAChRs including α3β4 in 
addition to α4β2. This same pharmacological antagonists that induces somatic withdrawal 
symptoms, has also been shown to alleviate anxiety-like behaviors during withdrawal from chronic 
nicotine217. This conflict suggests that the MHb’s role in regulating nicotine, nicotine withdrawal, 
and nicotine-induced anxiety-like behaviors is more complex than up- or down-regulation of 
vMHb firing alone but involves not yet understood signaling cascades by either β4- or α5-
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expressing nAChRs (or other nAChR subunits contained in the MHb). It is the balance of 
expression between β4- and α5-containing nAChR responses to acute nicotine that generates MHb-
induced nicotine aversion218. It has been recently demonstrated that the firing rate of the vMHb 
dictates the neurotransmitter released in the IPN; tonic firing appears to be glutamate dependent 
while long-lasting burst firing engages acetylcholine release219. This switch to acetylcholine 
release in the vMHb-IPN pathway is solely dependent on activation of β4-containing nAChR, as 
individual KO of all other nAChR subunits (including the α3 and α5) has no effect on vMHb 
acetylcholine release220. α5-containing nAChR mediated responses to nicotine, on the other hand, 
are dependent on concurrent neurokinin inputs221, so it is possible (but remains untested) that 
activation of α5-containing nAChRs is alone unable to alter nicotine sensitivity and MHb 
neurotransmitter release, but the combinatorial α5/neurokinin activation can engage comparable 
signaling mechanisms as β4-containing nAChR activation. As α5 and β4 subunits are often 
contained in function nAChR subtypes, it is likely the individual contributions of each subunit to 
the totality of nAChR function underlies these unique effects on nicotine response. Future studies 
will need to build upon this critical work to understand how MHb function is changed by each 
unique nAChR and ultimately regulate nicotine-associated behaviors.  
In Substance Use Disorder: Morphine 
 Various studies have shown the MHb holds (as like the case of nAChRs) the densest 
expression of the MOR1222,223 and deletion of MHb MORs significantly disrupts MHb-IPN 
connectivity224. Indeed, the MHb is sensitive to the effects of chronic morphine. Chronic morphine 
enhances MHb cholinergic signaling (as measured by decreases in acetylcholinesterase in the 
MHb-IPN junction and increased nAChR expression in the MHb)225,226. Disruption of MHb 
function subsequently disrupts behavioral and neural response to morphine. KO of RSK2 (a kinase 
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involved in CREB-regulated gene expression) in the vMHb blocks morphine-induced analgesia227. 
Although β4-KO decreases MHb activity during morphine withdrawal, it does not affect 
withdrawal behaviors226. However, β4 antagonists does block morphine self-administration and 
morphine-induced dopamine sensitization in the NAc (with no effect on acute morphine 
response)225,228, further iterating the role of the vMHb in behavioral and circuit adaptations. 
Despite the density of MOR in the MHb, it still remains unclear how altered MHb signaling during 
opioid exposure regulates behavioral responses. 
In Substance Use Disorder: Psychostimulants  
 Early pharmacological studies identified a regulatory role for the MHb in the responses to 
psychostimulants such as methamphetamine and cocaine. Lesions to the habenula block cocaine 
mediated effects on raphe serotonergic activity229. Blockade of the MHb-IPN enriched α3β4 
nAChR prevents various psychostimulant-associated behaviors such as methamphetamine self-
administration, cocaine self-administration, and cocaine-induced CPP211,230,231. Although the bulk 
of the literature has focused on nicotine’s effects on MHb function, there is growing evidence that 
the MHb responds to cocaine as well. Chronic cocaine leads to a desensitized response to future 
cocaine challenges in the MHb and a suppression of MHb activity that is only restored with a 
significantly increased dose of cocaine232. This contrasts with the response to chronic nicotine in 
the MHb, as chronic nicotine does not change baseline activity of vMHb neurons and nicotine 
withdrawal sensitizes the MHb to further nicotine challenges216,233, suggesting these two drugs of 
abuse have unique effects on habenula circuitry. Furthermore, the MHb shows increased cFos 
expression during cue-primed reinstatement of cocaine self-administration234, yet, presumptive 
VTA-projecting MHb neurons are not the engaged population235. Although it appears cocaine 
history alters MHb function, the underlying causes of long-term MHb changes remains elusive. 
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The MHb (enriched with GABAB receptors236) is preserved from chronic cocaine-induced changes 
to GABAB expression237. Additionally, DAT, the canonically studied site of cocaine antagonist 
function, is absent in the MHb. However, a dense non-raphe163 sourced serotonergic input does 
innervate the MHb (likely from the IPN165). The serotonin transporter is a known target of cocaine, 
radiolabeling studies have also shown cocaine binding sites in the MHb238, and, as previously 
mentioned, the MHb expresses a unique array of serotonin receptors sensitive to cocaine, including 
5-HT3A receptor170,239. Therefore, it is possible that repeated cocaine treatment alters this 
serotonergic input in a way that leaves the MHb primed for reinstatement of cocaine-associated 
behaviors.  
 Thus, this dissertation explores the MHb as a complex region involved in various motivated 
and drug-associated behaviors. Even though it is enriched with various regulators of cocaine-
associated behaviors (such as DARPP-32, HDAC3, and NR4A2), the molecular adaptations to 
cocaine within the MHb, as well as how the MHb may regulate cocaine associated behaviors have 
not been extensively studied. NR4A2 has been demonstrated to be necessary for vMHb 
development (as in VTA DA neurons)173, yet its role in the adult habenula remains 
uncharacterized. Does HDAC3 regulate MHb function through NR4A2? Does NR4A2 provide a 
similar function in associative processes in MHb-mediated behaviors as it does in the NAc and 
hippocampus? To answer these questions, I first observed the response of the MHb to cocaine-
primed reinstatement of cocaine-associated behaviors (Chapter 1). Then, I characterized a 
chemogenetic technique to manipulate memory formation and associative processes in behaving 
animals (Chapter 2) and investigated the role of cholinergic neurons within the vMHb in 
reinstatement of cocaine-associated behavior (Chapter 3). Lastly, I developed viral approaches to 
alter HDAC3 and NR4A2 function in the vMHb to study their influence on MHb-mediated 
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cocaine-associated behaviors (Chapter 4). Together, these experiments provide the first evidence 
for the role of HDAC3 and NR4A2 in the MHb in cocaine-associated behaviors. Furthermore, 
these studies contribute to the literature a function for the MHb in regulating cocaine response. 
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Chapter 1: Functional Adaptations of the Medial Habenula During Reinstatement 
of Conditioned Place Preference 
Rationale 
SUD is a chronic relapsing neuropsychiatric disorder that is underlied by long-lasting 
changes to neural circuit function. The relapsing nature of SUD is often modeled with stress-, 
drug-, or cue-primed reinstatement of drug-associated behavior models; much of the underlying 
circuitry regulating cue- and drug-primed reinstatement of cocaine-associated behaviors has been 
identified and is overlapping (although not necessarily identical). The MHb is one brain region 
whose function is altered by repeated cocaine exposures and has been linked to various cocaine-
associated behaviors, such as acquisition of cocaine-induced CPP and cue-primed reinstatement 
of self-administration. Yet, the full extent of cocaine treatments that alter MHb function, the 
epigenetic changes within the MHb in response to cocaine, and how these cocaine-induced 
changes to MHb function may fit into the circuitry regulating relapse-like behaviors is unknown. 
Our laboratory and others have shown that various epigenetic adaptations occur in response to 
repeated cocaine exposure and cocaine-associated behaviors. Here, we investigated the molecular 
response of the MHb to various cocaine exposures, consolidation of cocaine-induced CPP, and 
cocaine-primed reinstatement of CPP. 
Methods 
Animals: 
 8-week old wild-type c57BL/6J male mice were purchased from Jackson Laboratory. All 
mice were maintained on a 12:12hr ON/OFF light-dark cycle and were given ad libitum access to 
food and water. All experiments were conducted according to the National Institutes of Health 
guidelines for animal care and use and approved by the University of California, Irvine 
Institutional Animal Care and Use Committee.  
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Cocaine Exposure and Cocaine CPP-Reinstatement Paradigm: 
Chronic Cocaine Treatment: To test MHb activity during cocaine re-exposure, animals 
were handled for 2 min for 3 consecutive days. Following handling, animals received, in the 
homecage, cocaine-HCl (10mg/kg, I.P.) once/day for 7 consecutive days. Following 14d forced 
abstinence, animals received either saline or cocaine-HCl (5mg/kg, I.P.). 1 hr later, animals were 
sacrificed and brains flashfrozen on dry-ice chilled isopentane. 
CPP-Reinstatement Paradigm: Cocaine-induced CPP was performed as previously 
described42,144,240,241. Briefly, animals were handled for 2 min for 3 consecutive days. Following 
handling, mice were conditioned over 4 consecutive days, receiving either cocaine-HCl (10mg/kg, 
IP; Sigma) or 0.9% saline, in a context-dependent manner (counter-balanced, unbiased). Following 
conditioning, animals were allowed to freely explore, in a drug-free state, the complete chamber 
to assess preference, established as the difference between time spent in the cocaine-paired 
chamber and the saline-paired chamber, in seconds. To extinguish preference, animals were 
repeatedly reintroduced to the chamber, daily for 5 consecutive days. Once extinguished, animals 
were reinstated with either cocaine-HCl (5mg/kg, IP; Sigma) or 0.9% saline and allowed to freely 
explore the complete chamber for 15 minutes. 45 minutes following reinstatement session, animals 
were sacrificed and brains flash frozen on dry-ice chilled isopentane.  
Whole cell recording:  
Coronal slices (250-300 μm) through the thalamus were cut on a vibratome) and transferred 
into ASCF containing (in mM): 124 NaCl, 3 KCl, 1.25 KH2PO4, 1.5 MgSO4, 26 NaHCO3, 2.5 
CaCl2, and 10 dextrose. Recordings were made in a submerged chamber superfused with carbogen-
saturated ACSF at a speed of 2-3 ml / min., 32°C. Neurons of the medial habenular nuclei were 
identified using an upright fluorescence/brightfield microscope. Loose cell attached-recordings 
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(110-250 MΩ) were achieved from identified cells using infrared differential interference 
contrast160. Recordings (Axopatch 200A amplifier) were made with 5–7 MΩ pipettes filled with 
0.9% NaCl. Data were analyzed with pClamp (Molecular Device) and Minianalysis (Synaptosoft). 
RT-qPCR, fluorescent in-situ hybridization, and fluorescent immunohistochemistry:  
For RT-qPCR experiments, flash frozen 20um coronal sections and 500μm, 0.5mm2 
punches containing the Hb complex were collected using a Leica CM 1850 cryostat at -18°C. To 
examine c-fos expression, RNA was isolated from aforementioned punches using RNeasy Mini 
Kit (Qiagen, 74106) and total RNA was reverse-transcribed. cDNA was analyzed using Roche 
Light Cycler via Roche proprietary algorithms and REST 2009 software Pfaffl method242,243. All 
values were normalized to Gapdh expression levels generated simultaneously. Both cFos, Syt9, 
and gapdh primers were generated from Roche Universal Probe Library; c-fos: left c-Fos primer, 
5’-ggggcaaagtagagcagcta-3’; right c-Fos primer 5’-agctccctcctccgattc-3’; c-Fos probe 46, 
atggctgc; Syt9; left Syt9 primer, 5’ - ggagaactgtgcccatgc - 3’; right Syt9 primer 5’ – 
tgagctgtcttcggattgag – 3’; Syt9 probe 21; gapdh: right GAPDH primer, 5’-atggtgaaggtcggtgtga-3’, 
left GAPDH primer, 5’-aatctccactttgccactgc-3’, GAPDH probe, tggcggtattgg135. Syt9 is enriched 
in the MHb244 and was used to initially validate flash frozen punches can be taken to enrich for the 
MHb (Fig. 1.1A). 
For fluorescent in-situ hybridization, 20μM coronal sections were collected using a Leica 
CM 1850 cryostat at -18°C. For hybridization, a fluorescent oligodeoxynucleotide against cFos 
was used in an adapted hybridization protocol to quantitatively analyze gene expression245. Briefly, 
tissue was fixed in 4% PFA and blocked in 0.5% Triton X-100 in PBS. Tissue was then hybridized 
with a fluorescent cFos-specific probe [100nM] in hybridization buffer (4X SSC, 4% salmon 
sperm DNA, 0.5mM EDTA, 25% formamide in ddH2O,). Following hybridization, tissue was 
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washed in 2X SSC, incubated in DAPI [1:15000] in 0.1M PBS, and subsequently coverslipped 
using VectaShield Mounting Medium (product #H-1000). For immunohistochemistry slices were 
fixed in 4% PFA for 10 min, washed in 0.1M PBS, and permeated in 0.1% Triton X-100 in 0.1M 
PBS. Slices were then incubated in blocking serum (8% NGS, 0.3% Triton X-100, in PBS; 1 hr) 
and incubated at 4°C overnight in primary solution (2% NGS, 0.3% Triton X-100; anti-AcH4K8 
[1:1000], Cell Signaling #2594S). Slices were then incubated in secondary solution (2% NGS, 
0.3% Triton X-100; AcH4K8, goat anti-rabbit Alexa Fluor 488 [1:1000] in PBS). Tissue was 
imaged using Olympus Slide Scanner VSBX61. Fluorescence was quantified using ImageJ. 
Briefly, background signal was collected from a soma-free region and subtracted from MHb signal. 
All values were normalized to saline-reinstated controls.  
Data analysis:  
All data was analyzed and graphed using Graphpad Prism 7.02. 
Results 
The Hb complex responds to cocaine re-exposure following a period of forced abstinence  
Figure 1.1: The MHb responds to cocaine re-exposure. (A) Epithalamic punches (n=4) are significantly 
enriched for Syt9 (a marker for the MHb) compared to neighboring dorsal hippocampus (n=4; t3=10.39, p 
=0.0019). (B) Cocaine re-exposure (n=6) significantly increases cFos expression in the Hb complex compared to 
saline controls (n=5; t(9)=2.602, p=0.0286). (* indicates p ≤ 0.05, ** indicates ≤ 0.01) 
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Following 7 days of repeated cocaine administration (10 mg/kg, I.P.) and 14 days of forced 
abstinence in the home cage, animals received a cocaine re-exposure (5 mg/kg, I.P.) or saline. 
Cocaine re-exposed animals showed a significant increase in cFos expression in the Hb complex 
compared to saline injected controls (Fig. 1.1B).  
The MHb is functionally engaged during cocaine-primed reinstatement of CPP 
To determine if the MHb is engaged during cocaine-primed reinstatement of cocaine-
induced CPP, wild-type C57BL/6J mice were conditioned, extinguished, and reinstated with either 
saline or cocaine using a previously described counter-balanced protocol (Fig. 1.2A)132,144. Both 
saline-reinstated and cocaine-reinstated animals equally acquired and extinguished a conditioned 
preference (Fig. 1.2B and Fig. 1.2C). 24 hours following final extinction session, animals were 
primed with either saline or cocaine-HCl immediately prior to the reinstatement test. As predicted, 
cocaine-primed animals exhibited a significant increase in preference score compared to saline-
primed animals during the cocaine-primed reinstatement test. To limit analysis to the MHb, 
fluorescent in-situ hybridization was used to measure changes in cFos expression. In cocaine-
reinstated animals, we found a significant increase in cFos expression (Fig. 1.2E and 1.2F) and 
(using immunohistochemistry) an increase in acetylated H4K8 (Fig. 1.2G and 1.2H) in the MHb. 
We have observed that increased H4K8Ac associated with increased expression of c-Fos and 
Nr4a2 in a previous study132,240. The alterations in cFos expression within the MHb are not induced 
acutely following a single acquisition of cocaine-paired CPP (Fig. 1.2I, 1.2K) or a single injection 
of cocaine in the home cage (Fig. 1.2J, 1.2L). These data suggest that the MHb is engaged during 
cocaine-primed reinstatement of a cocaine-induced conditioned place preference.  
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To understand the direct effects of cocaine on MHb activity, we recorded from vMHb 
neurons of naïve or CPP extinguished animals. Bath application of cocaine (20μM) had no effect 
on the firing rate of vMHb neurons in naïve (Fig. 1.3A) or CPP extinguished animals. (Fig. 1.3B). 
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Moreover, we observed no differences baseline firing rate in the vMHb of naïve or CPP 
extinguished animals (Fig. 1.3C). 
Discussion 
Previous work has shown that chronic cocaine suppresses MHb activity that is restored by 
a subsequent increased dose of cocaine232. Yet, no studies have characterized the MHb response 
to cocaine following a period of forced abstinence. Here, we demonstrate that the Hb is activated 
(as measured by increase in cFos expression) by a cocaine re-exposure following abstinence from 
chronic cocaine treatment. From a technical perspective, even though punches are enriched with 
MHb tissue, it is more than likely collected tissue also contains LHb and paraventricular thalamus, 
two neighboring structures known to be altered by cocaine experience. Also, from a theoretical 
perspective, it is unclear if this increased activity during cocaine re-exposure is potentially linked 
to behaviors associated with repeated cocaine administration, such as cocaine-primed 
reinstatement. To address this, we adapted a fluorescent in-situ hybridization protocol that would 
Figure 1.2: The MHb is engaged by cocaine-primed reinstatement of CPP. (A) Cocaine-induced CPP cocaine-primed 
reinstatement paradigm. (B) Wild-type mice acquire cocaine-induced CPP (Two-way ANOVA, main effect of 
Conditioning: F(1,18)=56.15, p<0.0001), with no differences between saline-primed (n=9) and cocaine-primed animals 
(n=11) (Two-way ANOVA, No main effect of Reinstatement-Priming: F(1,18)=0.0958, p=0.7604). (C) CPP can be 
extinguished with repeated drug-free exposures to conditioning apparatus (Two-way ANOVA, main effect of Extinction: 
F(4,72)=17.99, p<0.0001); saline-primed and cocaine-primed animals extinguish equally (No main effect of Reinstatement-
priming, F(1,18)=0.1222, p=0.7308). (D) Cocaine-primed animals significantly reinstate previously extinguished cocaine-
induced CPP compared to saline-primed controls (Two-way ANOVA, main effect of Cocaine-Priming: F(1,18)=7.359, 
p=0.0143; Main effect of Reinstatement Session: F(1,15)=5.814, p=0.0268; effect of Interaction F(1,15)=7.431, p=0.0139). 
Sidak’s post-hoc analysis indicates cocaine-primed animals have a significantly increased preference during reinstatement 
test compared to final extinction session (t(15)=4.204, p=0.0015) and reinstatement of saline-primed controls (t(30)=3.829, 
p=0.0025).  (E) Representative images of FISH against cFos in the MHb of animal reinstated with (left) saline and 
reinstated with (right) 5mg/kg cocaine-HCl. (F) Cocaine-reinstated animals (n=10) show a significant increase in cFos 
hybridization reactivity in the MHb compared to saline-primed (n=8) controls (Welch’s corrected two-tailed t-test 
t(9.922)=2.467, p=0.0334) (G) Representative images of IHC against H4K8Ac in the MHb of (left) saline-reinstated animal 
and (right) cocaine-HCl reinstated animal. (H) Cocaine-reinstated animals (n=10) show a significant increase in H4K8Ac 
immunoreactivity in the MHb compared to saline-primed (n=7) controls (Two-tailed t-test t(15)=2.407, p=0.0294).  (I) A 
single cocaine (n=6, 10mg/kg) CPP conditioning session does not alter cFos expression in the MHb compared to saline-
paired controls (n=6, equal w/v) (t(10)=0.7891, p=0.4484). (J) An acute dose of cocaine (n=6, 10mg/kg) alone does not 
alter cFos expression in the MHb compared to saline-injected controls (n=6, equal w/v) (t(10)=1.5, p=0.1645). (K) A single 
cocaine (n=5, 5mg/kg) CPP conditioning session does not alter cFos expression in the MHb compared to saline-paired 
controls (n=5, equal w/v) (t(8)=0.09397, p=0.9274). (L) An acute dose of cocaine (n=6, 5mg/kg) alone does not alter cFos 
expression in the MHb compared to saline-injected controls (n=6, equal w/v) (t(10)=1.061, p=0.3137). (* indicates p ≤ 
0.05, *** indicates p ≤ 0.001, **** indicates p ≤ 0.0001) 
42 
 
allow for the quantification of cFos expression explicitly in the MHb following cocaine-primed 
reinstatement of CPP. Using this approach, we demonstrate that the MHb is activated during 
cocaine-primed reinstatement of extinguished CPP, but not during acute cocaine and cocaine-
associated memory formation. Also, we demonstrate that in response to cocaine-primed 
reinstatement, the MHb is in an epigenetically permissive state linked to the increased expression 
of IEGs, such as cFos and Nr4a2. This aligns with previous work demonstrating increased cFos in 
the MHb during cue-primed reinstatement of cocaine self-administration. However, in our 
electrophysiological experiments, cocaine alone was unable to induce stimulation of vMHb 
neurons from naïve or animals extinguished in CPP. This data suggests that the increases in MHb 
activity during cocaine re-exposure and cocaine-primed reinstatement are not mediated by 
cocaine’s direct influence on the MHb, but cocaine is acting upon inputs to the MHb to recruit 
MHb activity. Nevertheless, these observed changes do not causally link MHb function to the 
reinstatement of cocaine-associated behaviors, nor do they demonstrate an epigenetic regulation 
of MHb function.  
Figure 1.3: Cocaine does not directly alter vMHb activity. Bath application of cocaine-HCl (20μM) does not alter 
firing rate of vMHb neurons from (A) naïve (t(3)=1.857, p=0.1603) or (B) CPP extinguished (t(7)=1.743, p=0.1248) 
animals. (C) Baseline firing rates between naïve and extinguished animals show no significant difference 
(t(15)=0.7577, p=0.4604). 
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Chapter 2: Controlling Neuronal Function Through Chemogenetics 
Rationale 
We demonstrate various functional adaptations of the MHb to cocaine-associated 
behaviors, specifically, reinstatement of cocaine-primed CPP. However, these changes in function 
do not causally link the MHb to reinstatement behaviors. More so, due to the small size of the 
MHb and its proximity to the LHb and PVT, it does not easily lend itself to acute pharmacological 
manipulations. To address this, chemogenetics provides a novel method of controlling and 
studying neural function in behaving animals. Specifically, Designer Receptors Exclusively* 
Activated by Designer Drug (DREADDs) allow for a unique approach to investigate circuit 
activity of specific brain regions, circuits, and their role in driving behavior. DREADDs are a 
family of mutated muscarinic acetylcholine receptors that provide reversible activation of G-
protein coupled receptor (GPCR) signaling cascades that can induce depolarization (Gq, Gs) or 
hyperpolarization (Gi) upon application of clozapine-n-oxide (CNO). Although originally reported 
as an inert ligand, work from several groups has identified off-target effects of CNO and, in 
rodents, its back metabolism to clozapine246–248. Still, the use of DREADD-free controls combined 
with appropriate CNO concentrations make DREADDs a powerful method for providing gain-of- 
and loss-of-function manipulations in the CNS. 
Previous work has shown that these designer receptors can be effectively employed to 
bidirectionally modulate neuronal activity in a spatially and temporally specific manner249–255. To 
demonstrate feasibility of this technique in our hands, we utilized a DREADD approach to 
investigate their ability to regulate hippocampal LTP and hippocampus-dependent long-term 
memory. The novel object recognition (NOR) series of tasks have been widely used to assess 
memory formation256. These tasks exploit rodents’ inherent preference for novelty and can be used 
to study long-term memory formation in an incidental, noninvasive fashion. Recent work by our 
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lab and others, has shown that in rodents the object location memory (OLM) task is a 
hippocampus-dependent task. Specifically, OLM requires the dorsal region of the CA1 subfield 
for long-term memory retrieval102,112,113,257–262. Conversely, retrieval of memory in the object 
recognition memory (ORM) task, in rodents, has been shown to be hippocampus-independent, 
relying on cortical structures112,113,122,263. Here, we show DREADDs in the dorsal hippocampus 
can be used to bidirectionally modulate formation in the OLM task, but not ORM task. 
Surprisingly, however, we discovered promoter-specific effects of expressing DREADDs in the 
hippocampus on hippocampal LTP.  
Methods 
Animals:  
8-week old male c57BL/6J mice were purchased from Jackson Laboratory. Animals were 
maintained in 12:12 light/dark cycle with food and water provided ad libitum. All experiments 
were conducted according to the National Institutes of Health guidelines for animal care and use. 
Furthermore, experiments were approved by the Institutional Animal Care and Use Committee of 
the University of California, Irvine. 
Stereotaxic surgeries:  
For hSyn-HM3D experiments, animals received 1uL bilateral infusions to the dorsal 
hippocampus (ML: +/-1.5, AP: -2.0, DV: -1.5) of either AAV2.8-hSyn-GFP (n=10-12; viral titer 
3.7x1012) control or AAV2.8-hSyn-HA-HM3D-IRES-mCitrine (n=10-12; 2.3x1012). For hSyn-
HM4D experiments, animals received similar infusions of either AAV2.8-hSyn-GFP (n=10-12; 
3.7x1012) control or AAV2.8-hSyn-HA-HM4D-IRES-mCitrine (n=10-12; 4.2x1012). For CaMKIIα-
HM3D experiments, animals received 1uL bilateral infusions to the dorsal hippocampus of either 
AAV2.8-CaMKIIα-GFP (n=10-12; 5.6x1012) or AAV2.8-CaMKIIα-HA-HM3D-IRES-mCitrine 
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(n=10-12; 3.1x1012). For CaMKIIα-HM4D experiments, animals received similar infusions of 
either AAV2.8-CaMKIIα-GFP (n=10-12; 5.6x1012) or AAV2.8-CaMKIIα-HA-HM4D-IRES-
mCitrine (n=10-12; 3.3x1012). Viruses were infused at a rate of 100nl/min using a 30 gauge Neuros 
Hamilton syringe (Product #: 65459-01) mounted to either Harvard Apparatus Nanomite Syringe 
Pump (Product #: MA1 70-2217) or Leica Biosystems Nanoinjector Motorized f/Stereotaxics 
(Product #: 39462901). All infusions used the Leica Microsystems Angle Two Stereotaxic system. 
Animals were allowed to recover for 7 days prior to handling. Behavioral testing and 
electrophysiological recordings began at post-surgery day 21, to allow for full expression of 
DREADD receptors. 
Novel Object Recognition Tasks:  
NOR Tasks were carried out as previously described122,256. Briefly, animals were handled 
for 2 minutes over 5 consecutive days. Beginning on Day 4 of handling, animals were habituated 
for 5 min to the OLM chamber for 6 consecutive days in the absence of the test objects. Animals 
then underwent a task training session. For HM3D experiments, animals were presented with two 
identical 100mL beakers for 3 mins. For HM4D experiments, animals were presented with these 
OLM training objects for 10 mins. Animals were systemically injected 40 minutes prior to the 
training session with 3mg/kg of CNO (I.P, 0.3mg/ml, 0.5% DMSO, 0.9% saline; made fresh daily). 
Both GFP and DREADD-expressing animals were injected 40 minutes prior to behavior to allow 
for peak activation of DREADD receptors by CNO. After 24 hours, long-term memory formation 
was tested for 5 minutes, where the OLM training objects were presented, one of which in a novel 
location. Following OLM testing, animals were allowed to recover for 5 days. Animals were then 
habituated to the ORM chamber for 6 consecutive days in the absence of the test objects. For 
HM3D experiments, animals were presented with two identical objects (either metal tins or glass 
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candle holders) for 3 mins. For HM4D, animals were presented with these ORM training objects 
for 10 minutes. Both GFP and DREADD-expressing animals were systemically injected 40 
minutes prior to training session with 3mg/kg of CNO (I.P, 0.3mg/ml, 0.5% DMSO, 0.9% saline; 
made fresh daily). 24 hours later, animals’ retention was tested for 5 minutes, where one of the 
ORM training objects was replaced with a novel, previously unexplored object. Both the Training 
and Testing sessions were video recorded and hand scored by individuals blind to animal 
treatments. Videos were analyzed for total exploration of objects in addition to the discrimination 
index ([time spent exploring novel object - time spent exploring familiar object]/[total time 
exploring both objects]). 
Tissue harvesting for Immunohistochemistry and PCR: 
For HM3D experiments, at least 72 hours following testing, both HM3D and GFP animals 
received a subsequent dose of CNO, returned to their home cage, and sacrificed after 70 minutes. 
For HM4D experiments, at least 72 hours following testing, animals received a subsequent dose 
of CNO, returned to their home cage for 40 minutes, introduced to a novel context for 10 minutes, 
and sacrificed 30 minutes later. Because the HM4D virus was predicted to inhibit hippocampal 
activity, it would be difficult to interpret this by simply giving a subsequent CNO injection and 
returning to home cage. This would lead to a floor effect as there would be very limited basal 
hippocampal activity and would be difficult to parse out differences between GFP and HM4D 
animals. The introduction to the novel context was an attempt to induce hippocampal activity, 
which presumably the HM4D virus would have inhibited. For immunohistological and c-fos 
expression experiments, animals were cervically dislocated and brains flash frozen in chilled 
isopentane. Flash frozen 20um coronal sections and 500μm, 1.0mm2 punches of CA1 subfield of 
dorsal hippocampus were collected using a Leica CM 1850 cryostat at -18°C. To examine c-fos 
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expression, RNA was isolated using RNeasy Mini Kit (Qiagen, 74106) and total RNA (50ng) was 
reverse-transcribed. cDNA was analyzed using Roche Light Cycler via Roche proprietary 
algorithms and REST 2009 software Pfaffl method242,243. All values were normalized to Gapdh 
expression levels generated simultaneously. Both c-fos and gapdh primers were generated from 
Roche Universal Probe Library; c-fos: left c-Fos primer, 5’-ggggcaaagtagagcagcta-3’; right c-fos 
primer 5’-agctccctcctccgattc-3’; c-fos probe 46, atggctgc; gapdh: right GAPDH primer, 5’-
atggtgaaggtcggtgtga-3’, left GAPDH primer, 5’-aatctccactttgccactgc-3’, GAPDH probe, 
tggcggtattgg135. For verification of viral expression in electrophysiological experiments, RNA was 
isolated using RNeasy Mini Kit (Qiagen, 74106) and total RNA was reverse-transcribed. cDNA 
was analyzed using Bio-Rad MJ Mini-Personal Thermal Cycler for expression of either HM3D or 
HM4D viruses. Both HM3D and HM4D primers were generated from Roche Universal Probe 
Library; hm3d: left HM3D primer, 5’-agtacaacctcgcctttgtttc-3’; right HM3D primer, 5’-
atcggaggggctgtgtatc-3’; hm4d: left primer, 5’-tgaagcagagcgtcaagaag-3’; right HM4D primer, 5’-
tcctccagcttgccattg-3’. 
Immunohistochemistry:  
To confirm expression of DREADD, flash frozen sections were mounted to glass slides 
and stained for HA tag. Briefly, slices were fixed in 4% PFA for 10 minutes, washed twice in 0.1M 
PBS for 5 minutes, and quenched in 1.5% H2O2 for 20 minutes. Tissue was permeated with a single 
5 min wash in 0.1% Triton X-100 in PBS solution, PBS-washed three times for 5 minutes, and 
blocked for an hour in 8% Normal Goat Serum, 0.3% TX-100 in 0.1M PBS. Following 3, 5-min 
PBS washes, slices were incubated overnight in an HA primary antibody solution containing anti-
HA ([1:1000], Roche Diagnostics, Rat monoclonal, Product #: 11867423001), 2% NGS, 0.3% TX-
100 in PBS at 4°C. Slices were washed three times for 5 minutes in PBS. Slices were then 
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incubated in secondary solution (Alexa Fluor Goat anti-Rat 555 [1:1000], 2% NGS, 0.3% TX-100, 
in PBS) for 2 hours at RT. Following secondary incubation slices were washed 3 times for 5 
minutes in PBS, incubated in DAPI [1:15000] in PBS, and washed in PBS 3 times. Slides were air 
dried and coverslipped with VectaShield Mounting Medium (Product #: H-1000). Tissue was 
imaged using Olympus Scanner VSBX61 to confirm expression of either HA-tagged DREADD 
receptor or GFP control. 
Slice preparation and electrophysiological recording:  
Hippocampal slices were prepared as previously described102. Briefly, following isoflurane 
anesthesia, mice were decapitated and the brain was quickly removed and submerged in ice-cold, 
oxygenated dissection medium containing (in mM): 124 NaCl, 3 KCl, 1.25 KH2PO4, 5 MgSO4, 26 
NaHCO3, and 10 glucose. Transverse hippocampal slices (375 µm) through the mid-third of the 
septotemporal axis of the hippocampus were prepared using a FHC vibrating tissue slicer 
(Model:OTS-5000) before being transferred to an interface recording containing preheated 
artificial cerebrospinal fluid (aCSF) of the following composition (in mM): 124 NaCl, 3 KCl, 1.25 
KH2PO4, 1.5 MgSO4, 2.5 CaCl2, 26 NaHCO3, and 10 glucose and maintained at 31°C. Slices were 
continuously perfused with this solution at a rate of 1-1.5 ml/min while the surface of the slices 
were exposed to warm, humidified 95% O2 / 5% CO2. Recordings began following at least 1.5 hr 
of incubation. 
Field excitatory postsynaptic potentials (fEPSPs) were recorded from CA1b stratum 
radiatum using a single glass pipette (2-3 MΩ). Stimulation pulses (0.05Hz) were delivered to 
Schaffer collateral-commissural projections using a bipolar stimulating electrode (twisted 
nichrome wire, 65 µm) positioned in CA1c. Current intensity was adjusted to obtain 50% of the 
maximal fEPSP response. In a separate set of experiments, antagonists of the AMPA and NMDA 
49 
 
receptors were infused to block the negative-going fEPSP that is characteristic of excitatory 
transmission leaving a positive-going evoked response that is blocked by picrotoxin, a GABAA 
receptor antagonist (field inhibitory postsynaptic potential; fIPSP)264,265. Input/output curves were 
established before testing began to adjust current intensity that produced near maximal responses.  
After establishing a 10-20 min stable baseline, compounds were introduced into the 
infusion line by switching from control aCSF to drug-containing aCSF. To determine whether 
CNO treatment affects the threshold level of LTP in slices from hSyn-GFP control, hSyn-HM3D, 
and hSyn-HM4D infused mice, LTP was induced by delivering 3 theta bursts, with each burst 
consisting of four pulses at 100 Hz and the bursts themselves separated by 200 msec (theta burst 
stimulation; TBS). The stimulation intensity was not increased during TBS. Data were collected 
and digitized by NAC 2.0 Neurodata Acquisition System (Theta Burst Corp., Irvine, CA).  
Reagents:  
For behavioral experiments, CNO was provided by the National Institute of Mental Health 
Chemical Synthesis and Drug Supply Program. For electrophysiological experiments, DNQX 
(Tocris Biosciences), D-(-)APV (Tocris Biosciences), and picrotoxin (Sigma) were prepared fresh 
in aCSF, while a 10mM stock solution of CNO (abcam# 141704) was dissolved in water and 
subsequently diluted to a working concentration (5μM) in aCSF. 
Data analysis:  
All statistical tests were performed using GraphPad Prism 5. Habituation data (distance 
traveled during individual habituation sessions), training, and testing videos were collected using 
ANY-maze behavioral analysis software. Habituation was analyzed using a 2-way ANOVA 
comparing total distance travelled across the habituation sessions. Training and testing data was 
analyzed using a Student’s t-test comparing either exploration or discrimination index between 
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control and test animals. Slice physiology data in the text are presented as means ± SD and fEPSP 
slope was measured at 10–90% fall of the slope. Data in figures on LTP were normalized to the 
last 10 min of baseline and presented as mean ± S.E. CNO-induced changes on baseline measures 
were analyzed using a paired-Student’s t-test comparing pre-CNO with post-CNO infusion period 
and assessed as significant if p < 0.05. Baseline measures on paired-pulse facilitation and LTP 
were analyzed using a 2-way ANOVA.  
Results 
hSyn-HM3D-dependent activation of the dorsal hippocampus can transform subthreshold 
training into LTM in OLM, but not ORM 
To test if activation of the dorsal hippocampus during a subthreshold training event can 
lead to LTM, hSyn-HM3D and hSyn-GFP infused animals received CNO 40 min prior to a 3 min 
training session. Human synapsin-1 is ubiquitously expressed throughout neurons and viruses 
employing the hSyn promoter have been shown to have high neuron-specific expression266. We 
have previously shown that a 3 min training period is insufficient to generate long-term memory 
tested at 24 hours112–114,263. Following CNO-primed training, animals were tested for LTM in the 
OLM task (Fig. 2.1A). hSyn-HM3D animals showed a significant increase in DI compared to 
hSyn-GFP controls during the test session (t(19)=3.387, p=.0031), demonstrating that HM3D-
mediated activation in the hippocampus transforms a subthreshold training period into robust LTM 
for object location (Fig. 2.1Bii). There were no differences between groups in training DI (Figure 
2.1Bi; t19=0.6511, p=0.5228), habituation (F1,5=0.02544, p=0.8749), training exploration 
(t19=1.083, p=0.2924), or test exploration (t19=0.2446, p=0.8094) in the OLM experiment (data not 
shown).  
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Following testing in the OLM task, animals underwent a similar training and testing 
paradigm in the ORM task (Fig. 2.1A). hSyn-HM3D animals tested for LTM in the ORM task 
following CNO-primed training showed no difference in DI compared to hSyn-GFP controls 
(t(19)=0.05526, p=0.9565), demonstrating that HM3D-mediated activation in the hippocampus 
does not affect LTM for object recognition (Fig. 2.1Biv). There were no measurable differences 
between groups in training DI (Figure 2.1Biii; t19=1.240, p=0.23), habituation (F1,5=0.4782, 
p=0.4976), training exploration (t19=0.9064, p=0.3761), or test exploration (t19=0.5898, p=0.5623) 
in the ORM experiment (data not shown).  Immunohistochemistry was used to verify expression 
of both hSyn-GFP and hSyn-HM3D viruses (Fig 2.1C). To confirm in-vivo hSyn-HM3D function, 
animals received a subsequent dose of CNO before being sacrificed. RT-qPCR was used to 
measure cfos expression in tissue collected from the dorsal hippocampus. Tissue expressing hSyn-
HM3D showed a dramatic increase in normalized cfos:GAPDH expression compared to hSyn-
GFP control following a subsequent dose of CNO (Fig. 2.1D; t(12.46)=8.637, p<0.0001). These 
results suggest that chemogenetic activation of the during training can transform a subthreshold 
learning event into LTM for OLM, a hippocampus specific task, but not for ORM. 
hSyn-HM4D-dependent inactivation can block LTM formation in OLM, but not ORM 
To test if dorsal hippocampus inactivation can block LTM formation during a training 
event that normally generates LTM, we administered CNO 40 min prior to 10 min training of 
hSyn-HM4D and hSyn-GFP infused animals. We have previously shown that a 10 min training 
period is sufficient for generating reliable LTM tested at 24 hours112,114,122,256. 24 hours following 
CNO-primed training, animals were tested for LTM in the OLM task (Fig. 2.1E). hSyn-HM4D 
animals showed a significant decrease in DI compared to hSyn-GFP controls during the test 
session (t(22)=2.177, p=0.0405), demonstrating that HM4D-mediated inhibition of the dorsal 
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hippocampus disrupts LTM for object location (Fig. 2.1Fii). There were no measurable differences 
between groups with regard to training DI (Figure 2.1Fi; t22=0.6071, p=0.55), habituation 
(F1,5=0.3796, p=0.5441), training exploration (t22=0.4126, p=0.6839), or test exploration 
(t22=1.934, p>0.05) in the OLM experiment (data not shown).  hSyn-HM4D animals were 
subsequently tested for LTM in the ORM task following CNO-primed training and showed no 
difference in DI compared to hSyn-GFP controls (t(21)=0.2171, p=0.8302), demonstrating that 
HM4D-mediated inhibition of the dorsal hippocampus does not affect LTM for object recognition 
Figure 2.1: Bidirectional modulation of dorsal hippocampus via hSyn-DREADDs affects long-term memory 
processes. (A) Subthreshold training and testing paradigm for Novel Object Recognition tasks. (B) Training and testing 
discrimination indices of hSyn-GFP (white) and hSyn-HM3D (blue), shown as mean ± S.E.M. (i) Mean discrimination 
index for OLM training, (ii) Mean discrimination index for OLM testing, (iii) Mean discrimination index for ORM 
training (iv) mean discrimination index for ORM testing. (C) Immunohistochemistry against DAPI (blue), GFP (green), 
and HA (red) in hSyn-GFP or hSyn-HM3D infused dorsal hippocampus. (D) Normalized RT-qPCR measuring relative 
c-fos:GAPD expression in hSyn-GFP (white) and hSyn-HM3D (blue). (E) Threshold training and testing paradigm for 
Novel Object Recognition tasks. (F) Training and testing discrimination indices of hSyn-GFP (white) and hSyn-HM4D 
(red), shown as mean ± S.E.M. (i) Mean discrimination index for OLM training, (ii) Mean discrimination index for OLM 
testing, (iii) Mean discrimination index for ORM training (iv) mean discrimination index for ORM testing. (G) 
Immunohistochemistry against DAPI (blue), GFP (green), and HA (red) in hSyn-GFP or hSyn-HM4D infused dorsal 
hippocampus. (H) Normalized RT-qPCR measuring relative c-fos:GAPD expression in hSyn-GFP (white) and hSyn-
HM4D (red). For HM3D OLM and ORM experiments, hSyn-GFP n=10 and hSyn-HM3D n=11. For HM4D OLM 
experiments, hSyn-GFP n=11, hSyn-HM4D n=12. For HM4D ORM experiments, hSyn-GFP n=12, hSyn-HM4D n=12. 
(* indicates p ≤ 0.05, ** indicates p ≤ 0.01,  *** indicates p ≤ 0.001 
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(Fig. 2.1Fiv). There were no measurable differences between groups in training DI (Figure 
2.1Fiii; t21=0.5423, p=0.5933), habituation (F1,5=0.3923, p=0.5379), training exploration 
(t21=1.034, p=.3127), or test exploration (t21=0.9842, p=.3362) in the ORM experiment (data not 
shown). 
Together, these results indicate that inhibition of dorsal hippocampal activity during 
training sufficient for LTM can block the formation of LTM for OLM, but not for ORM. 
Expression of hSyn-GFP and hSyn-HM4D viruses was confirmed immunohistologically (Fig. 
2.1G). To confirm in-vivo hSyn-HM4D function, animals received a subsequent dose of CNO and 
RT-qPCR was used to measure cfos expression in tissue collected from the dorsal hippocampus. 
Surprisingly, tissue expressing hSyn-HM4D also showed a dramatic increase in normalized 
cfos:GAPDH expression compared to hSyn-GFP control following a subsequent dose of CNO 
(Fig. 2.1H; t(22)=3.483, p=0.021). The cause of this cfos induction is unknown and could be 
attributed to several factors, including interneuron function throughout the dorsal hippocampus. 
To more accurately characterize the hSyn-mediated effects on hippocampal function, we evaluated 
DREADD modulation electrophysiologically. 
hSyn-dependent expression of DREADD receptors differentially affects synaptic 
transmission and LTP in hippocampal field CA1 
We predicted that chemogenetic activation (HM3D-Gq) would increase synaptic 
transmission and LTP, whereas chemogenetic inhibition (HM4D-Gi) would block synaptic 
transmission and LTP in the dorsal hippocampus. We tested these predictions in acute 
hippocampal slices prepared from hSyn-GFP-control, hSyn-HM3D, and hSyn-HM4D infused 
mice. CNO infusions had no detectable influence on fEPSP slope and amplitude in slices from 
hSyn-GFP animals (Fig. 2.2A and 2.2B). However, unexpectedly, CNO application to hSyn-
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HM3D expressing slices caused a substantial decrease in the slope and amplitude of the fEPSP 
relative to pre-CNO infusion (Fig. 2.2A, 2.2B, and 2.2D). Field responses in slices from hSyn-
HM4D mice also produced surprising results. CNO-application to hSyn-HM4D expressing slices 
caused a transient increase in slope, while the amplitude of the field response remained 
significantly elevated 20 min into the washout period relative to pre-CNO baseline values. 
Strangely, engagement of hSyn-HM3D inhibits glutamatergic signaling in the dorsal 
hippocampus, while engagement of hSyn-HM4D appears to enhance glutamatergic signaling 
(aligning with the enhanced cFos expression seen in Fig. 2.1H). It is important to note that while 
the hSyn-promoter does provide neuronal specificity, it does not provide neuronal cell-type 
specificity. It is possible that both the unexpected cFos induction in hSyn-HM4D expressing 
animals and the counter-intuitive electrophysiological effects are mediated by DREADD-mediated 
changes in local GABA neuron activity. 
To test the role of hippocampal GABA-interneurons in CNO-induced changes, we 
pharmacologically isolated the fIPSP. In the dorsal hippocampus, fIPSPs can be isolated using 
combined AMPA and NMDA receptor antagonists; this fIPSP is picrotoxin (PTX)-sensitive, 
demonstrating it is mediated by GABAA receptor activation (Fig. 2.2Ei). Following a stable 
baseline recording, the fIPSP remained unchanged during a 20 min CNO infusion period in hSyn-
GFP expressing slices (Fig. 2Ei). However, CNO application on hSyn-HM4D expressing slices 
blocked the fIPSP in the dorsal hippocampus, while CNO application on hSyn-HM3D expressing 
slices enhanced the fIPSP (Fig. 2Eii). Collectively, these results suggest that, hSyn-HM4D 
increases excitatory drive in the dorsal hippocampus through inhibition of local GABA neurons, 
while hSyn-HM3D inhibits the fEPSP by activating local GABA neurons. 
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We subsequently tested how these DREADD-mediated changes would effect changes in 
LTP. TBS in CNO-treated slices from hSyn-GFP injected mice produced strong short-term 
potentiation that gradually stabilized over a 20 min period to a level that was +27±12% above pre-
TBS baseline 60 min post-induction (Fig. 2.3). CNO-pretreatment in hSyn-HM4D expressing 
slices enhanced TBS-induced LTP, while in hSyn-HM3D expressing animals, CNO-pretreatment 
impaired TBS-indued LTP (Fig. 2.3). The enhancement in LTP in hSyn-HM4D slices is consistent 
with previous studies showing that blocking GABAA receptor activation enhances LTP in area 
 
Figure 2.2: Characterization of baseline synaptic transmission in hippocampal slices expressing hsyn-driven 
excitatory and inhibitory DREADD receptors.  (A-C) Hippocampal slices were prepared from adult GFP-control (grey 
circle, n=6), hSyn-HM3D (green circle, n=7), and hSyn-HM4D (red circle, n=6) mice. The graphs show the mean ± S.E.M. 
fEPSP (A) slope, (HM3D; t(6)=5.3, p=0.0018; HM4D; (t(5)=4.5, p=0.006) (B) amplitude, (t(6)=4.4, p=0.004)  and (C) half-
width plotted as a percent change of baseline in hippocampal slices treated for 20 min with 5 μM CNO followed by a 
washout. (D) representative field responses collected from GFP-control, hSyn-HM3D, and hSyn-HM4D slices during the 
baseline recording period (Pre-CNO) and 30 min after the end of CNO infusion (Post-CNO). Calibration: 1 mV, 5 ms. (E) 
(i) Pharmacologically isolated field IPSP amplitudes (responses recorded in the presence of 20 μM DNQX and 100 μM 
APV, antagonists for AMPA and NMDA receptors, respectively) were evoked by stimulation of the Schaffer-commissural 
projections (Pre-CNO, grey line, upper trace) in slices prepared from GFP-control animals (n=5 slices). Graph shows the 
mean ± S.E.M. change in field IPSP amplitude as a percent change of baseline. These responses were completely blocked 
by the GABAA receptor antagonist picrotoxin (PTX, black line, upper traces) and were unaffected by infusions of 5 μM 
CNO (blue line, upper traces). Calibration: 0.1 mV, 10 ms. (ii) In slices prepared from hSyn-HM3D mice (n=7 slices), CNO 
infusions produced a delayed but significant increase in the fIPSP; t(5)=3.0, p=0.03. In contrast, CNO infusions mimicked 
the effects of PTX by causing a dramatic decrease in the fIPSP and completely eliminating the field response 30 min after 
the end of the infusion period in slices (n=5) from hSyn-HM4D mice. Field IPSP were unaffected by infusions of CNO in 
slices from GFP-controls (n=5) during the recording session. Calibration: 0.1 mV, 10 ms. 
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CA1267,268. To confirm viral infusions in hSyn-HM3D and hSyn-HM4D slices, PCR on collected 
tissue was used with primers specific to either HM3D or HM4D receptors to rule out the possibility 
of crossed viral infusion; i.e. to validate that the inhibitory effect of the hSyn-HM3D virus is not 
due to being accidentally injected with hSyn-HM4D, but is truly a characteristic of the hSyn-
HM3D virus and vice-versa. PCR with primers specific to the HM3D virus yielded bands only in 
tissue isolated from HM3D animals. Moreover, PCR with primers specific to the HM4D virus 
yielded bands only in tissue isolated from HM4D animals, thus, precluding the possibility of virus 
cross-contamination (data not shown). Taken together, these studies strongly suggest that the 
hSyn-mediated DREADD expression transduces a global population of neurons in hippocampal 
region CA1 that regulate both excitatory and inhibitory synaptic inputs. 
Targeting the excitatory cell-population via promoter specificity corrects for predicted 
outcome on synaptic transmission and long-term plasticity. 
Figure 2.3: Long-term plasticity changes associated with hSyn-driven DREADD receptor expression 
in adult hippocampal slices. The slope of the fEPSP was normalized to the mean of the last 60 responses 
(10 min) collected in the presence of 5 uM CNO before application of theta burst stimulation (upward 
arrow). A single train of 3 theta bursts was effective in inducing stable potentiation in slices from GFP-
control mice (n=6), but produced a supranormal amount of potentiation in slices from hSyn-HM4D mice 
(n=6). In contrast, theta burst-induced LTP decayed toward baseline values in slices from hSyn-HM3D 
(n=6) mice. main effect of DREADD F(2,15)=73, p=0.001 Inset: Traces collected during the last 5 min of 
CNO treatment (grey line) and 60 min post-TBS (black, green, and red lines). Calibration: 1 mV, 5 ms 
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To limit DREADD-mediated effects to the gutamatergic population of the dorsal 
hippocampus, we use CamkIIα driven viral vectors. Use of the CamkIIα promoter has been shown 
to restrict viral expression to forebrain excitatory neurons269–272. Thus, we predicted animals 
infused with the CaMKIIα-regulated HM3D and -HM4D DREADD receptors would alter 
excitatory transmission in a positive and negative manner, respectively. In agreement with our 
hypotheses, bath applied CNO (5μM) caused a rapid increase in glutamatergic transmission 
beginning 5-10 min after the start of infusion in slices prepared from animals treated with 
CaMKIIα-HM3D (Fig. 2.4A). In CaMKIIα-HM4D expressing slices, CNO caused a significant 
drop, in fEPSP slope that was 15% below baseline values, while the synaptic responses collected 
from CaMKIIα-GFP-control slices remained unchanged during the infusion and recording session. 
(Fig. 2.4A). We then tested CNO’s effects on theta burst-induced LTP in CaMKIIα-HM3D and –
HM4D infused mice. Consistent with our previous predictions, TBS in CaMKIIα-GFP expressing 
Figure 2.4: Promotor-specific effects of CaMKIIα DREADD receptors on synaptic transmission and long-term 
plasticity. (A) Following stable baseline recordings, infusions of CNO (5 uM) produced a rapid increase in field responses 
collected from CaMKIIα-HM3D (n=8) slices. In contrast, CNO infusions caused a marked decrease in fEPSP slope in 
slices from CaMKIIα-HM4D (n=6) mice. Field responses from CaMKIIα-GFP (n=6) slices were unaffected by CNO 
infusion. Inset: Representative traces collected during baseline recording (grey line) and 10 min after the end of CNO 
infusion (colored lines). Calibration: 1mV, 5 ms. (B) The slope of the fEPSP was normalized to the mean of the last 60 
responses (10 min) collected in the presence of 5 uM CNO before application of theta burst stimulation (upward arrow). 
A single train of 3 theta bursts delivered at the end of CNO infusion period was sufficient to induce short-term potentiation 
that then stabilized for the remainder of the recording period in control slices (CaMKIIα-GFP, n=6), but not in slices from 
CaMKIIα-HM4D (n=6). The same train applied at the end of the CNO infusion generated robust and stable LTP that was 
greater in magnitude in slices from CaMKIIα-HM3D (n=8) mice than controls. Inset: Traces collected during the last 5 
min of CNO treatment (grey line) and 60 min post-TBS (black, green, and red lines). Calibration: 1 mV, 5 ms 
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slices pretreated with CNO (+32±7%). CNO-pretreatment on CaMKIIα-HM3D expressing slices 
generated a significantly enhanced TBS- (+59±11%) that was suppressed in CaMKIIα-HM4D 
expressing slices.  
CaMKIIα-HM3D-dependent activation of dorsal hippocampus can transform subthreshold 
training into LTM in OLM, but not ORM 
 Although the effects of CaMKIIα-HM3D excitation of the dorsal hippocampus on LTP 
were as predicted, it was necessary to compare these hippocampal synaptic plasticity results to 
those of hippocampal learning. To test if CaMKIIα-HM3D mediated excitation of the dorsal 
hippocampus can transform a subthreshold training event into LTM, CaMKIIα-HM3D and 
CaMKIIα-GFP infused animals received CNO 40 min prior to a 3 min training session (Fig. 2.5A). 
24 hours following CNO-primed training, animals were tested for LTM in the OLM task. 
CaMKIIα-HM3D animals showed a significant increase in DI compared to CaMKIIα-GFP 
controls (t(21)=4.774, p=0.0001), demonstrating that HM3D-mediated excitation in the 
hippocampus transforms a subthreshold training period into robust LTM for object location (Fig. 
2.5Bii). There were no significant differences between groups in training DI (Figure 2.5Bi; 
t(21)=0.01476, p=0.9884) or test exploration (t(21)=1.298, p=0.2082) (data not shown). However, 
there was a modest, yet statistically significant, increase in CaMKIIα-HM3D animals’ training 
exploration (7.891 +/-0.3704 sec) compared to CaMKIIα-GFP (6.394 +/-0.4156 sec) (t(21)=2.698, 
p=0.0135). Furthermore, there was a significant difference in habituation (F(1,5)=4.821, p=0.0395). 
However, a Bonferroni post-test revealed the difference was only significant during Day 1 of 
habituation and was no longer significant throughout Days 2-6, suggesting that both groups of 
animals equally habituated to the OLM training context prior to training (data not shown).  
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Following OLM testing, animals were subsequently trained and tested in the ORM task 
(Fig. 2.5A). CaMKIIα-HM3D and CaMKIIα-GFP animals tested for LTM in the ORM task 24 
hours following CNO-primed training showed no difference in DI compared to CaMKIIα-GFP 
controls (t(21)=0.1542, p= 0.8789), with no measureable differences in habituation (F(1,5)=3.276, 
p=0.0846), training DI (Figure 2.5Bii; t(21)=0.1478, p=0.8839), training exploration (t21=1.079, 
p=0.2928), or test exploration (t(21)=1.079, p=0.2928) (data not shown). Expression of either 
CaMKIIα-GFP or CaMKIIα-HM3D in the dorsal hippocampus was confirmed 
immunohistologically (Fig. 2.5C). These results indicate that CaMKIIα-HM3D mediated 
excitation of the dorsal hippocampus parallels the electrophysiological effects on LTP and 
transforms the subthreshold training event into LTM for the OLM task, but not the ORM task. 
CaMKIIα-HM4D-dependent inactivation of the dorsal hippocampus can block LTM 
formation in OLM, but not ORM 
 To test if CaMKIIα-HM4D mediated inhibition of dorsal hippocampal neurons can disrupt 
LTM formation, we primed 10-min training of CaMKIIα-HM4D or CaMKIIα-GFP infused 
animals with CNO administration. 24 hours following CNO-coupled training, animals were tested 
for LTM in the OLM task (Fig. 2.5D). CaMKIIα-HM4D animals showed a significant decrease in 
DI compared to CaMKIIα-GFP controls (Fig. 2.5Eii; t(21)=5.490, p<0.0001), with no significant 
differences in training DI (Figure 5Ei; t(21)=1.296, p=0.2090), habituation (F(1,5)=0.0569, 
p=0.8136), training exploration (t(21)=0.4539, p=0.6545), or test exploration (t(21)=0.5871, 
p=0.5634) (data not shown).  Animals were subsequently tested for LTM in the ORM task 24 
hours following CNO-primed training (Fig. 2.5D). CaMKIIα-HM4D animals showed no 
differences in testing DI compared to CaMKIIα-GFP controls (Fig. 2.5Eiv; t(22)=0.1125, 
p=0.9114). Moreover, there were no measurable differences in training DI (Figure 5Eiii; 
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t22=0.07847, p=0.9382), habituation (F1=0.2521, p=0.6206), training exploration (t22=0.6564, 
p=0.5184), or test exploration (t22=0.8065, p=0.4286) (data not shown). Immunohistochemistry 
was used to confirm expression of CaMKIIα-GFP or CaMKIIα-HM4D (Fig. 2.5F). These results 
suggest that CaMKIIα-HM4D mediated inhibition of the dorsal hippocampus parallels the 
electrophysiological effects on LTP and is able to prevent the formation of LTM for the OLM task, 
but not the ORM task.  
Discussion 
Figure 2.5: Modulation of dorsal hippocampus via CaMKIIα-DREADDs leads to bidirectional changes in long-term 
memory processes. (A) Subthreshold training and testing paradigm for Novel Object Recognition task. (B) Training and 
testing discrimination index of CaMKIIα-GFP (white) and CaMKIIα -HM3D (blue), shown as mean ± S.E.M. (i) Mean 
discrimination index for OLM training, (ii) Mean discrimination index for OLM testing, (iii) Mean discrimination index 
for ORM training (iv) mean discrimination index for ORM testing. (C) Immunohistochemistry against DAPI (blue), GFP 
(green), and HA (red) in CaMKIIα-GFP or CaMKIIα -HM3D infused dorsal hippocampus. (D) Threshold training and 
testing paradigm for Novel Object Recognition task. (E) Training and testing discrimination index of CaMKIIα-GFP 
(white) and CaMKIIα-HM4D (red), shown as mean ± S.E.M. (i) Mean discrimination index for OLM training, (ii) Mean 
discrimination index for OLM testing, (iii) Mean discrimination index for ORM training (iv) mean discrimination index 
for ORM testing. (F) Immunohistochemistry against DAPI (blue), GFP (green), and HA (red) in CaMKIIα-GFP or 
CaMKIIα-HM4D infused dorsal hippocampus. For HM3D OLM and ORM experiments, CaMKIIα-GFP n=11, CaMKIIα-
HM3D n=12. For HM4D OLM experiments, CaMKIIα-GFP n=12, CaMKIIα-HM3D n=11. For HM4D ORM experiments, 
CaMKIIα-GFP n=12, CaMKIIα-HM3D n=12. (*** indicates p ≤ 0.001) 
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We implemented DREADDs to bidirectionally modulate the dorsal hippocampus to 
validate the use of DREADDs in a well characterized behavioral paradigm. Both hSyn-HM3D- 
and CaMKIIα-HM3D-mediated activation of the dorsal hippocampus were able to transform a 
subthreshold learning event into LTM for object location, but not object recognition. Additionally, 
hSyn-HM4D- and CaMKIIα-HM4D-mediated inactivation of the same region was able to block 
LTM formation for object location, but not object recognition. These behavioral results support 
previous findings in mice that the dorsal hippocampus appears to be particularly involved in object 
location memory, but not object recognition102,113,122,256,258,259. Memory for object recognition 
appears to be more dependent on the perirhinal cortex273–275 and the insular cortex275,276. However, 
the role of the hippocampus in memory for object recognition is more controversial257,260, as results 
tend to be dependent on various parameters including species and stime between training and 
testing113,275,277. 
Most importantly in this study, we discovered promoter-specific effects of expressing 
DREADDs in the hippocampus on hippocampal LTP. The function of DREADDs on hippocampal 
LTP induced by TBS, a neuronal firing pattern occurring during exploratory behavior in rodents278, 
had not previously been investigated. The hSyn-HM3D and hSyn-HM4D behavioral experiments 
led us to predict that hSyn-HM3D expression in the hippocampus would produce an enhancement 
in LTP, while an impairment in LTP was expected in slices from hSyn-HM4D expressing mice. 
Surprisingly, application of CNO to slices expressing hSyn-HM3D in the dorsal hippocampus, led 
to a significant decrease in amplitude of fEPSP and blocked TBS-induced LTP. In contrast, 
application of CNO to slices expressing hSyn-HM4D led to a significant increase in fEPSP 
amplitude and an enhancement of TBS-induced LTP. Our electrophysiological data suggest that 
CNO-induced depression of field responses in hSyn-HM3D mice may be driven by activation of 
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local GABA interneurons279,280, while hSyn-HM4D mediated increase of fEPSP appears to be 
driven by GABA interneuron suppression. These results suggest that data obtained with hSyn 
promoter driven DREADDs should be carefully interpreted, particularly when used in adult ex-
vivo tissue with diverse local subpopulations. 
The contrast between electrophysiological and behavioral results via hSyn-mediated 
altered signaling remains poorly understood. The disparate results may largely be due to non-
specific viral infected cells within local interneuron population which are known to tightly regulate 
activity of CA1 pyramidal cells in this region263,281,282. hSyn viral expression in local interneurons 
would explain the increase in cfos expression following CNO exposure in hSyn-HM4D infused 
mice (See Fig. 2.1H). Interestingly, numerous reports have shown a dissociation between 
hippocampal LTP and hippocampus-dependent LTM using genetically modified mice283–289. It is 
important to note (and it is often overlooked in studies implementing the DREADD technique) 
that that changes in neuronal firing are nothing more than a convenient artifact of the GPCR 
signaling cascades engaged by CNO-DREADD interaction. While it is convenient to catalog 
HM3D as an excitatory DREADD and HM4D as an inhibitory DREADD, this subtle lack of 
accuracy has the potential to cause inconsistencies in interpreting chemogenetic results. In this 
study, we demonstrate that hSyn-HM3D suppresses fEPSP in the dorsal hippocampus. Yet, in vivo, 
hSyn-HM3D significantly induced cFos expression, to an extent that is unlikely mediated by 
increased firing of GABA neurons responsible for the fEPSP suppression. This suggests that while 
there was electrophysiological inhibition, intracellularly, the Gq signaling cascade was still being 
engaged, leading to the curious results on gene expression and may underlie the enhancement in 
hippocampus-dependent learning despite fEPSP inhibition. Nevertheless, DREADDs still provide 
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an avenue of cell-type specific manipulations that can be relatively easily adapted to study the role 
of the MHb in relapse-like behaviors.  
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Chapter 3: Medial Habenula Cholinergic Neurons Regulate Cocaine-primed 
Reinstatement 
Rationale 
Propensity to relapse, even following long periods of abstinence, is a key feature in SUD. 
Relapse and relapse-like behaviors are known to be induced, in part, by re-exposure to drugs of 
abuse and/or drug-associated cues. Yet, while many critical nodes in the neural circuitry 
contributing to relapse have been identified and studied, a full description of the networks driving 
reinstatement of drug-seeking behaviors is lacking. One area that may provide further insight to 
the mechanisms of relapse is the MHb. Due to the density of cholinergic neurons and the 
expression of unique nicotinic acetylcholine receptors (including the β4 and α5 subunits) in the 
vMHb, much of the addiction field has focused on nicotine-associated behaviors179,210,215,290,291. 
The cholinergic population of the vMHb has been shown to be necessary for nicotine self-
administration, withdrawal, and the aversive properties of nicotine215,218,292. While it is clear the 
vMHb has a key role in regulating nicotine response and behavior, few studies have extensively 
evaluated how the vMHb regulates the response to other drugs of abuse223,224,227. Recent work, 
however, implicates the cholinergic population of the MHb in regulating self-administration and 
reinstatement behavior of other psychostimulants, including cocaine and 
methamphetamine209,225,228. Yet, the mechanisms by which the MHb may modulate the behaviors 
associated with cocaine are unknown. We have previously demonstrated (See Chapter 1) that the 
MHb is activated during cocaine-primed reinstatement of CPP. The goal of this study is to 
investigate how the MHb may regulate relapse-like behavior and adaptive response to cocaine. 
Here, we use a cell-type specific chemogenetic approach to causally link vMHb activity to changes 
in cocaine-associated behaviors. 
Methods 
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Animals: 
ChAT-IRES-CreCre/Cre mice were purchased from the Jackson Laboratory (Stock No. 
006410). Male and female heterozygous ChAT-IRES-Cre mice (ChAT-Cre) were bred and 
maintained in 12 h light/dark cycle with food and water provided ad libitum. All experiments were 
conducted according to the National Institutes of Health guideline for animal care and use. 
Experiments were approved by the Institutional Animal Care and Use Committee of the University 
of California, Irvine. 
Stereotaxic Surgeries: 
2-5-month-old heterozygous ChAT-Cre mice received 0.5μL bilateral infusions to the 
medial habenula (M/L, +/-0.35mm; A/P, -1.5 mm; D/V; -3.0) of AAV2.8-hSyn-DIO-HM3D-Gq-
mCherry (2.2 x 1012 vg/ml) or AAV2.8-hSyn-DIO-mCherry (5.3 x 1012 vg/ml). Viruses were 
infused at a rate of 100nl/min using a 30 gauge Neuros Hamilton syringe (product #65459-01) 
mounted to either a Harvard Apparatus Nanomite Syringe Pump (product #MA1 70-2217) or Leica 
Biosystems Nanoinjector Motorized f/Stereotaxics (product #39462901)293. All infusions used the 
Leica Microsystems Angle Two Stereotaxic System. For behavioral experiments, animals were 
allowed to recover for a minimum of 7 d before handling. For electrophysiological recordings, 
animals were allowed to recover for a minimum of 4 w before recording. 
Chemogenetic Viruses:  
All viruses were purchased from UNC Vector Core (HM3D Lot: AV4979bc, 2013, 
mCherry Lot: AV4981CD, 2014) or AddGene (HM3D Lot: v4330, 2016). Viral cDNA was 
extracted with Proteinase K in 1%SDS/10mM Tris-HCl in water and viral purity of chemogenetic 
constructs was confirmed via Sanger Sequencing (Genewiz) and Endpoint PCR. Universal 
Amplification Forward Primer: 5’ - gccacccttggtcaccttcag - 3’, Universal Amplification Reverse 
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Primer: 5’ - gccatacgggaagcaatagca - 3’. Universal Sequencing Primer: 5’ -cgatctcgaactcgtggccgt 
- 3’  
Whole cell recording:  
Coronal slices (250-300 μm) through the thalamus were cut on a vibratome) and transferred 
into ASCF containing (in mM): 124 NaCl, 3 KCl, 1.25 KH2PO4, 1.5 MgSO4, 26 NaHCO3, 2.5 
CaCl2, and 10 dextrose. Recordings were made in a submerged chamber superfused with carbogen-
saturated ACSF at a speed of 2-3 ml / min, 32°C. Labeled neurons of the medial habenular nuclei 
were identified using an upright fluorescence microscope. Loose cell attached-recordings (110-
250 MΩ) were achieved from identified fluorescent cells using infrared differential interference 
contrast160. Recordings (Axopatch 200A amplifier) were made with 5–7 MΩ pipettes filled with 
0.9% NaCl. Data were analyzed with pClamp (Molecular Device) and Minianalysis (Synaptosoft). 
CPP-Reinstatement Paradigm:  
Cocaine-induced CPP was performed as previously described42,144,240,241. Briefly, animals 
were handled for 2 min for 3 consecutive days. Following handling, mice were conditioned over 
4 consecutive days, receiving either cocaine-HCl (10mg/kg, IP; Sigma) or 0.9% saline, in a 
context-dependent manner (counter-balanced, unbiased). Following conditioning, animals were 
allowed to freely explore, in a drug-free state, the complete chamber to assess preference, 
established as the difference between time spent in the cocaine-paired chamber and the saline-
paired chamber, in seconds. To extinguish preference, animals were repeatedly reintroduced to the 
chamber, daily for 6 consecutive days. Once extinguished, animals received either 3mg/kg CNO 
(0.3mg/ml CNO, 0.5% DMSO, 0.9% saline, IP) or vehicle (0.5% DMSO, 0.9% saline) 40 minutes 
prior to being reinstated with 0.9% saline. Animals were sorted post-hoc into reinstatement groups 
following extinction to ensure reinstatement groups equally acquired and extinguished preference. 
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For CNO Acquisition experiments, animals received on alternating days either 3mg/kg CNO 
(0.3mg/ml CNO, 0.5% DMSO, 0.9% saline, IP) or vehicle (0.5% DMSO, 0.9% saline) 40 minutes 
prior to 30-minute conditioning sessions. Behavior was assessed and analyzed using Ethovision 
XT 11.5. 
Immunohistochemistry: 
Animals were euthanized and brains flash frozen in dry ice-chilled isopentane. 20μM 
coronal sections were collected using a Leica CM 1850 cryostat at -18°C. For 
immunohistochemical confirmation of HM3D or mCherry expression, MHb containing slices 
were fixed in 4% PFA for 10 min, washed in 0.1M PBS, and permeated in 0.1% Triton X-100 in 
0.1M PBS. Slices were then incubated in blocking serum (8% NGS, 0.3% Triton X-100, in PBS; 
1 hr) and incubated at 4°C overnight in primary solution (2% NGS, 0.3% Triton X-100; anti-
DsRed [1:1000], Clontech #1408015). Slices were then incubated in secondary solution (2% NGS, 
0.3% Triton X-100; DsRed, Alexa Fluor goat anti-rabbit 555; in PBS). Tissue was imaged using 
Olympus Slide Scanner VSBX61.  
Data analysis:  
All data was analyzed and graphed using Graphpad Prism 7.02. 
Results 
Chemogenetic activation of the cholinergic MHb population reinstates place preference 
To establish a causal link between MHb activity and reinstatement of cocaine-induced 
CPP, we employed a chemogenetic approach to selectively activate the vMHb during 
reinstatement. DIO-HM3D(Gq)-mCherry was infused bilaterally in the MHb of ChAT-IRES-
CreCre/+ knockin mice (called ChAT-Cre mice). ChAT-Cre animals have been shown to effectively 
limit expression of Cre-dependent (DIO) constructs within cholinergic cell populations, 
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particularly in the MHb (Fig. 3.1A)294. First, we examined whether engagement of Gq-coupled 
Figure 3.1: Combinatorial approach using Cre-dependent DREADD in Cre-drive line. (A) Immunohistochemistry 
against DIO-HM3D(Gq)-mCherry; (i) coronal and (ii) sagittal sections show limited expression of mCherry-tagged HM3D 
DREADD to MHbChAT population. (iii) Coronal section of IPN shows expression of HM3D DREADD in axon terminals 
in the IPN, known to receive dense innervation from the cholinergic population of the vMHb. (B) Mean firing rate during 
baseline and following CNO (10μM) infusion. HM3D-mCherry expressing MHb neurons (n=6) showed a 110.2 ± 39.5% 
increase in firing rate following CNO application (Paired t-test, t(5)=6.574, p=0.0012) (C) When normalized to baseline, 
HM3D-mCherry expressing MHb neurons showed a significant increase in percent change in firing rate (t(5)=2.787, 
p=0.0386). (D) Frequency of spiking for HM3D-mCherry expressing MHb cells during infusion, as a function of baseline 
values (E) Loose seal recordings from representative fluorescent MHb neuron prior to Baseline and two minutes following 
CNO (10μM) infusion. (* indicates p ≤  0.05, ** indicates p ≤ 0.01). 
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signaling increases firing of MHb ChAT expressing neurons. DIO-HM3D was injected bilaterally 
in the MHb of ChAT-Cre mice and recordings made with loose seal (110 – 250 MΩ) clamps from 
labeled neurons in coronal slices through the medial habenula prepared from mice injected at least 
4 weeks previously160. Recording was continued until a stable, ten-minute baseline rate (0.5 to 9.0 
Hz) of spontaneous spiking was collected. CNO (10μM) was then infused for an additional ten 
minutes. The agonist increased firing frequency within 1-2 minutes of application in all cells 
examined (Fig. 3.1B-D, representative trace Fig. 3.1E). The mean increase in rate was 110.2 ± 
39.5% (Fig. 3.1B and 3.1C), with the largest percent effects occurring in cells with an initially low 
spiking rate (Fig. 3.1D), demonstrating that HM3D-mCherry expressing MHb ChAT neurons can 
be activated chemogenetically, in a CNO-dependent manner. 
To determine if chemogenetic activation of MHb ChAT expressing neurons is sufficient 
for reinstatement of cocaine-induced CPP, we infused DIO-HM3D bilaterally into the MHb of 
ChAT-Cre mice. HM3D-infused ChAT-Cre animals underwent CPP conditioning and extinction 
as previously described (Fig. 3.2A). HM3D-infused animals both acquired (Fig. 3.2B) and 
extinguished (Fig. 3.2C) a cocaine-induced CPP, with no differences between CNO-reinstated and 
Veh-reinstated animals. To test whether activity within MHb ChAT expressing neurons is 
sufficient to drive reinstatement of a cocaine-induced CPP, we administered CNO or vehicle 40 
min prior to a saline-primed reinstatement session. We found CNO-primed animals had a 
significantly increased preference score compared to Veh-primed controls during the reinstatement 
test (Fig. 3.2D). Additionally, we did not find sex-dependent effects on CPP acquisition between 
males (n=8) and females (n=9) (Two-way ANOVA, no main effect of Sex, F(1,15)=0.5065, 
p=0.4876; no Sex-Conditioning interaction, F(1,15)=1.172, p=0.2961) nor sex-dependent effects on 
extinction (No main effect of Sex, F(1,15)=0.01755, p=0.8964). Although there was a Sex-
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Extinction Interaction (F(5,75)=2.734, p=0.0253), Sidak’s post-hoc analysis does not indicate any 
significant differences between sexes across extinction trials. Lastly, our initial analyses did not 
find a Sex-dependent effect on CNO-induced reinstatement between males (n=6) and females 
(n=3) (No Sex-Reinstatement Interaction, F(1,7)=3.242, p=0.1148; no main effect of Sex, 
F(1,7)=0.5496, p=0.4836) (data not shown). Thus, chemogenetic activation of MHb ChAT 
Figure 3.2: Chemogenetic activation of MHbChAT artificially induces reinstatement of CPP. (A) Cocaine-induced 
CPP CNO-primed reinstatement paradigm. (B) ChAT-Cre HM3D infused mice acquire cocaine-induced CPP (Two-way 
ANOVA, main effect of Conditioning, F(1,15)=37.52, p<0.0001), with no differences between CNO-primed (n=9) and 
Veh-primed (n=8) animals (No main effect of CNO-Priming F(1,15)=0.1159, p=0.7383). (C) CPP in HM3D-infused 
animals is subsequently extinguished with repeated drug-free exposures to chamber (Two-way ANOVA, main effect of 
Extinction, F(5,75)=9.002, p<0.0001). Both CNO-primed and Veh-primed animals extinguish CPP equally (No main effect 
of CNO-Priming, F(1,15)=0.0055152, p=0.9437). (D) CNO-primed animals significantly reinstate previously extinguished 
cocaine-induced CPP (Two-way ANOVA, Interaction between CNO-Priming and Reinstatement Session, F(1,15)=16.02, 
p=0.0012;  main effect of CNO-Priming, F(1,15)=8.721, p=0.0099). Sidak’s post-hoc analysis reveals a significant increase 
in preference score during reinstatement session in CNO-primed animals compared to final extinction session (t(15)=5.07, 
p=0.0003) and compared to reinstatement of Veh-primed animals (t(30)=2.988, p=0.0111). (E) CNO-induced CPP 
paradigm. (F) CNO alone is unable to establish a conditioned place preference or aversion in either mCherry-infused 
(n=6) or HM3D-infused (n=6) animals (No main effect of CNO Conditioning, F(1,10)=3.749, p=0.0816; No main effect of 
DREADD, F(1,10)=0.3974, p=0.5426; No Interaction, F(1,10)=0.431, p=0.5263). Although there may be a trend of CNO 
Conditioning, Sidak’s post-hoc analysis shows no significant difference in change in preference score of mCherry-infused 
animals (t(10)=0.9049, p=0.6240) or HM3D-infused animals (t(10)=1.833, p=0.1839). (* indicates p ≤ 0.05, ** indicates p 
≤ 0.01, **** indicates p ≤ 0.0001) 
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expressing neurons artificially induces reinstatement behavior in previously cocaine-conditioned 
animals, even in the absence of cocaine, demonstrating that the cholinergic signaling in the MHb 
mediates behavioral effects of cocaine-primed reinstatement. 
Activation of cholinergic MHb neurons does not induce CPP or CPA 
We have demonstrated that MHb cholinergic neurons are sufficient for inducing 
reinstatement of cocaine-induced CPP, mimicking the drug-primed phenotype. However, how 
activity in the vMHb, specifically the cholinergic population, affects reward processing and 
associative learning remains unclear. Thus, we tested if chemogenetic activation of the MHb ChAT 
expressing neurons alone induces a conditioned preference or aversion. ChAT-Cre animals were 
infused bilaterally with either DIO-mCherry or DIO-HM3D in the MHb. Animals were 
subsequently handled and underwent an adapted CNO-primed CPP paradigm where animals 
received alternating conditioned pairings of Veh (0.5% DMSO, 0.9% saline; I.P.) or CNO (3 
mg/kg, 0.5% CNO, 0.9% saline; I.P) 40 minutes prior to exposure to conditioning chambers (Fig. 
3.2E). 24 hours following final conditioning session, animals were tested for preference for or 
aversion to CNO-paired chamber, in a CNO-free state. We found no effect of CNO-conditioning 
in either DIO-mCherry or DIO-HM3D animals during post-test (Fig. 3.2F). These data suggest 
that activation of the MHb is unable to induce a conditioned preference or aversion. 
CNO administration does not induce reinstatement behavior in DREADD-free mice 
Recent work has further characterized the pharmacological mechanism by which 
chemogenetic manipulations, specifically DREADDs, function. Others have demonstrated that 
CNO alone has no effect on reinstatement behaviors or psychostimulant self-administration295–299. 
However, Gomez et al. implicates clozapine as the specific ligand to DREADDs and its back 
metabolism from CNO to engage DREADD-mediated changes in cell function (2017). Due to the 
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potential psychoactive effects of clozapine, we next tested if the chemogenetic-induced 
reinstatement (see Fig. 3.2D) and changes to MHbACh firing rate (see Fig. 3.1B-D) were due to 
engagement of the expressed DREADD-receptor or an off-target effect of CNO exposure. We 
infused DIO-mCherry in the MHb of ChAT-Cre mice. DIO-mCherry infused animals 
subsequently underwent CPP acquisition and extinction as previously described (Fig. 3.3A). 
mCherry-infused animals both acquired (Fig. 3.3B) and extinguished (Fig. 3.3C) a cocaine-
Figure 3.3: CNO-priming does not induce reinstatement of CPP in DREADD-free animals. (A) Cocaine-induced 
CPP CNO-primed reinstatement paradigm. (B) ChAT-Cre DIO-mCherry infused mice acquire cocaine-induced CPP 
(Two-way ANOVA, main effect of Conditioning, F(1,9)=30.56, p=0.0004), with no differences between CNO-primed 
(n=6) and Veh-primed (n=5) animals (No effect main effect of CNO-priming (F(1,9)=0.4273, p=0.5297). (C) CPP in 
mCherry-infused animals is subsequently extinguished with repeated drug-free exposures to chamber (Two-way 
ANOVA, main effect of Extinction, F(5,45)=10.77, p<0.0001). Both CNO-primed and Veh-primed animals extinguish CPP 
equally (No main effect of CNO-priming, F(1,9)=0.7064, p=0.4224). (D) CNO-primed animals show no significant 
reinstatement of previously extinguished cocaine-induced CPP compared to Veh-primed controls (Two-way ANOVA, no 
main effect of Reinstatement, F(1,9)=0.06347, p=0.8068; no main effect of CNO-priming, F(1,9)=0.5076, p=0.4942). (E) 
Mean firing rate during baseline and following CNO (10μM) infusion. mCherry expressing MHb neurons (n=11) show 
no significant change in firing rate following CNO application (Paired t-test, t(10)=0.1149, p=0.9108). (F) When 
normalized to baseline, mCherry expressing MHb neurons show no significant increase in percent change in firing rate 
(t(10)=1.382, p=0.1971). (*** indicates p ≤ 0.001, **** indicates p ≤ 0.0001). 
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induced CPP, with no differences between CNO-reinstated and Veh-reinstated animals. To test 
whether CNO is sufficient to drive reinstatement of a cocaine-induced CPP in DREADD-free 
animals, we administered CNO or vehicle 40 min prior to a saline-primed reinstatement session. 
We found no difference between CNO-primed or Veh-primed controls during reinstatement test 
(Fig. 3.3D). We further demonstrate that CNO alone has no effect on firing rate of DREADD-free 
MHb-ChAT neurons. CNO (10μM) was infused in MHb containing slices of DIO-mCherry 
infused animals with no effect on firing rate in mCherry-expressing MHb-ChAT neurons (Fig. 
3.3E & 3.3F), demonstrating that effects on firing and reinstatement behavior occur in a 
CNO/DREADD combinatorial fashion. 
Discussion 
In this study, using chemogenetics, we more causally linked activity within the MHb with 
changes in reinstatement behavior. DREADD-mediated activation of MHb ChAT expressing 
neurons artificially induces reinstatement for a previous cocaine-induced CPP, demonstrating that 
vMHb activity is sufficient for inducing reinstatement, even in the absence of cocaine. We further 
demonstrate that chemogenetic activation of the vMHb is unable to induce a preference or aversion 
alone. Others found that modulating cholinergic signaling in nicotine-naïve animals has no effect 
in mediating anxiety-like behaviors, supporting the notion that neuroplastic adaptations within the 
vMHb pathway are altered and recruited by repeated exposure to drugs of abuse to drive reward-
associated and reward-seeking behaviors217. Conversely, previous work has shown that artificial 
activation of the dMHb is reinforcing and is able to induce intracranial self-stimulation; 
meanwhile, optogenetic inhibition of the dMHb elicits a conditioned place aversion300. Together, 
these results highlight the unique roles of MHb subcircuits within the MHb-IPN axis that should 
be further studied. 
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Although we selectively modulate cholinergic neurons of the MHb, this cell population has 
been previously shown to release glutamate and/or acetylcholine169,219,301. Therefore, it remains 
unclear which neurotransmitter system is responsible for driving the reinstatement phenotype. 
Recently, it has been demonstrated that MHb firing rate alters the neurotransmitter system used by 
the vMHb; tonic firing appears to engage glutamatergic transmission, while high-rate phasic firing 
drives acetylcholine release219. Given the significant increase in firing induced by CNO exposure 
in HM3D-expressing MHb cells (see Fig. 3.1D), it is likely that acetylcholine is being utilized in-
vivo to induce reinstatement behavior. Studies have linked vMHb-IPN circuit activity with changes 
in median raphe nuclei and ventral tegmental function; downregulation of cholinergic signaling in 
the vMHb leads to a depressive-like phenotype correlated with increase in serotonergic function 
from the median raphe, whereas increases in MHb signaling activates ventral tegmental 
dopaminergic neurons and suppresses raphe serotonin167. It is possible that similar changes to 
cholinergic signaling within these pathways occur during cocaine-primed reinstatement. 
 Previous work in the field has implicated the ChAT-expressing MHb population in 
processing the aversive properties of nicotine and the negative affect throughout nicotine 
withdrawal179,210. Work from Fowler and Kenny demonstrated that α5-KO (α5-expressing 
nAChRs are enriched in the vMHb-IPN pathway) mice show escalations of nicotine self-
administration through a blunting of the aversive properties of nicotine and not an increase in the 
rewarding aspects of the drug215,302. Conversely, pharmacological antagonists of β4-expressing 
nAChR (also enriched in the vMHb-IPN pathway) inhibit the self-administration of morphine, 
cocaine and blocks the formation of cocaine CPP228,230,231. It is likely that a balance between α5- 
and β4-containing nAChRs is more influential in regulating drug response than a single 
subunit214,218. Yet, how cocaine and nicotine exposure differentially affect MHb activity remains 
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a key open question. MHb activity may regulate the rewarding properties of other drugs of abuse, 
while encoding for the aversive properties of nicotine. Conversely, due to the population of nAChR 
in the MHb, but absence of known cocaine targets (dopamine transporter, serotonin transporter, 
and norepinephrine transporter), it is possible that nicotine can directly modulate MHb activity, 
while other drugs of abuse, such as cocaine, engage the adaptive behaviors with which MHb 
function has been associated. 
 Recent work has brought into question the exclusivity of CNO as the ligand for DREADDs 
and demonstrated that rodents are capable of CNO to clozapine back-metabolism246. While it has 
been shown that CNO is not significantly back metabolized to clozapine in mice, it is possible that 
the limited clozapine produced is sufficient to induce DREADD activity reported in Gomez et al., 
while being subthreshold for off-target effects303. Moreover, while it has been demonstrated that 
systemic clozapine is able to induce changes in neural activity, these changes occur in response to 
significantly higher doses (35 mg/kg) than what could be back metabolized from our doses of CNO 
(3 mg/kg)247,248,304. Within this current study, the inability of CNO alone to induce a conditioned 
preference/aversion (see Fig. 3.2E), induce reinstatement (see Fig. 3.3D), or induce changes in 
MHb firing rate (see Fig. 3.3E & 3.3F) support the idea that it is not CNO alone, or potential back 
metabolism to clozapine, that is mediating the observed effects during reinstatement. 
How the MHb is recruited to regulate cocaine-reinstatement behaviors remains unclear, 
especially considering that the main targets of cocaine action (dopamine transporter, 
norepinephrine transporter, and serotonin transporter) are largely absent within the MHb. Recent 
work characterized the downstream targets of the MHb-IPN pathway and show that serotonergic 
raphe nuclei receive dense innervation from vMHb-innervated IPN neurons164. The MHb also 
densely expresses the 5-HT3A, -4, -5A, and -5B receptors, suggesting it receives serotonergic 
76 
 
inputs, potentially from the same raphe-serotonergic population receiving innervation from the 
IPN170,175,305. It is possible that these inputs may be directly, but differentially, modulated by 
cocaine and nicotine.  
The above study demonstrates a specific function of the vMHb in the reinstatement of 
cocaine-induced CPP and adds to the growing body of work implicating the MHb in substance use 
disorders. The most relevant study with regard to cocaine is from James et al. (2011), which 
demonstrated changes in MHb activity during cue-primed reinstatement of cocaine self-
administration234. MHb activity was indirectly measured using Fos protein expression (as in our 
studies in Chapter 1) from rats following reinstatement. In support of this approach (measuring 
Fos expression), James et al. (2011) found high-reinstating animals exhibited higher Fos 
expression in the medial habenula as compared to low-reinstating animals. There remain numerous 
key open questions regarding the role of the MHb in reinstatement. How are specific molecular 
mechanisms engaged within the MHb (such as the increases in H4K8Ac shown in Chapter 1), 
and how do they contribute to drug-associated behaviors? As the MHb is a key regulator of 
withdrawal and relapse-like behaviors, do long-lasting molecular adaptations (such as epigenetic 
modifications) within the MHb confer the persistence and resilience of drug-associated memories 
and drug-seeking behavior?  
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Chapter 4: Epigenetic Control of Habenula-mediated Cocaine-associated 
Behaviors 
Rationale 
 We have shown that the MHb is engaged during cocaine-primed reinstatement of cocaine-
induced CPP. Moreover, using chemogenetics, we demonstrate that activity in the cholinergic 
neurons of the MHb is sufficient to induce reinstatement, providing a causal link between MHb 
function and relapse-like behaviors. We have also observed increases in H4K8Ac (apermissive 
epigenetic mark) in the MHb during cocaine-primed reinstatement. H4K8Ac has been associated 
with disengagement of HDAC3 deacetylase activity and increased Nr4a2 expression135,240,306. 
NR4A2 is a powerful regulator of associative learning that is enriched in the vMHb and is induced 
in the MHb by conditioned learning197. However, it remains unclear if this reinstatement-induced 
H4K8Ac in the MHb is linked to HDAC3 disengagement, if these changes occur at Nr4a2, and if 
NR4A2 in the MHb is necessary for reinstatement behaviors. In the following studies, we assay 
HDAC3 at the promoters of various plasticity genes in the cholinergic neurons of the MHb and, 
using a viral approach, examine the role of HDAC3 enzymatic activity in cocaine-associated 
behaviors. Lastly, we use a recently discovered dominant-negative variant of NR4A2 (NURR2C) 
to determine if NR4A2 in the MHb is necessary for reinstatement of CPP.  
Methods 
Animals: 
ChAT-IRES-CreCre/Cre (ChAT-Cre; Stock No. 006410) and Lox-STOP-Lox-TdTomato 
mice (TdTomato; Stock No. 007909) were purchased from the Jackson Laboratory. Male and 
female ChAT-Cre were bred and maintained as heterozygous. Male and female LSL-
TdTomato::ChAT-Cre (TdChAT) were bred as heterozygous for TdTomato and ChAT-Cre genes 
and genotype confirmed via end-point PCR. All mouse lines were maintained on a c57BL/6J 
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background. Mice were given ad libitum access to food and water while housed under a 12-h light 
cycle in a climate-controlled room. All experiments were conducted during the light portion of this 
cycle. Genotyping primers used are as follow: ChAT-IRES-Cre WT Forward: 5’ –
gtttgcagaagcggtggg– 3’, ChAT-IRES-Cre Shared Reverse: 5’ – agatagataatgagaggctc – 3’, ChAT-
IRES-Cre Mutant Forward: 5’- ccttctatcgccttcttgacg – 3’; Cre recombinase Forward: 5’ – 
ggtcgatgcaacgagtga – 3’, Cre recombinase Reverse: 5’ – ccctgatcctggcaattt – 3’; TdTomato WT 
Forward: 5’ – aagggagctgcagtggagtat – 3’, TdTomato WT Reverse: 5’ – ccgaaaatctgtgggaagtc – 3’, 
TdTomato Mutant Forward: 5’ – ctgttcctgtacggcatgg – 3’, TdTomato Mutant Reverse: 5’ – 
ggcattaaagcagcgtatcc – 3’. 
Cloning and Viral packaging: 
Wild-type HDAC3 (HDAC3W.T.), loss of function HDAC3 (HDAC3Y298H), and NURR2C 
were PCR amplified from mouse cDNA. HDACY298H was generated via a single nucleotide 
substitution of Tyrosine 298 with a histidine. NURR2C was generated through deletion of Nr4a2 
Exons 3 and 7, as previously identified307.  
For Cre-independent vectors, NURR2C-V5 or untagged NR4A2 was cloned under the 
Camkiiα promoter with the addition of β-globin intron to generate pAAV-CaMKIIα-βGlobin-
NURR2C-V5 or  pAAV-CaMKIIα-βGlobin-NR4A2 (untagged). For Cre-dependent vectors, 
products were subsequently cloned into a modified pAAV-hSyn-DIO-eGFP (Addgene #50457, a 
generous gift from Dr. Bryan Roth) with the addition of β-globin intron. GFP element was removed 
from the original vector and replaced with a V5-tag, generating a fusion to HDAC3W.T., 
HDAC3Y298H, and NURR2C.  
Determining NR4A2/NURR2C Interaction 
79 
 
HT22 cells (Salk Institute, La Jolla, CA) were Lipofectamine LTX with Plus Reagent 
(ThermoFisher, Waltham , MA) transfected with 1μg of CamKIIα-βGlobin-NURR2C-V5 with or 
without 1μg CamKIIα-βGlobin-NR4A2 (untagged). 48 hours later, cells were harvested, lysed in 
tissue lysis buffer (T-PER, ThermoFisher; 1X HALT protease inhibitor) and pelleted. Samples 
were centrifuged (13,000RPM, 10 min, 4°C) and supernatant aliquoted for immunoprecipitation. 
5ul of total was set aside for Input positive control while 500ul of sample were incubated overnight 
at 4°C with 20ul Protein G (Invitrogen) beads, 5.25ul 100X HALT protease inhibitor, and 5ul of 
Mouse anti-V5 (Invitrogen #:46-0705). The following day samples were precipitated on a chilled 
magnet and washed for 5 minutes in 500ul of the following wash series: Low Salt Immune 
Complex, High Salt Immune Complex, LiCl Immune Complex Wash Buffer, and TE Buffer. 
Immediately following the final wash, samples were magnet precipitated, resuspended in 20uL of 
T-PER, heated to 75°C for 10min, and eluted from magnetic beads in 10.5ul NuPAGE LDS 
Sample Buffer/Sample Reducing Agent. Samples were immunoblotted using the Invitrogen XCell 
SureLock Mini-Cell and XCellII Blot Module. Western blot was blocked in blocking buffer (5% 
powdered milk, 0.1% Tween-20, 1X TBS) for 1 hr at room temperature. NR4A2 immunoreactivity 
was assayed using mouse anti-NR4A2 (abcam#: ab41917, [1:1000]) or V5-selectivity using mouse 
anti-V5 (Invitrogen) in primary buffer (3% BSA, 0.1% Tween-20, 1X TBS) overnight at 4°C, 
triple washed in 0.1% Tween-20, 1X TBS for five minutes, and incubated with goat anti-mouse 
secondary (light-chain specific, HRP-conjugated [1:5000]) in secondary buffer (5% powdered 
milk, 0.1% Tween-20, 1X TBS) for 1 hr at room temperature. Blot was subsequently triple washed 
in 0.1% Tween-20, 1X TBS for five minutes and incubated in SuperSignal West Pico PLUS for 
protein detection. 
Determining Cre-dependent expression 
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To confirm Cre-dependent expression of cloned plasmids, HT22 cells (Salk Institute, La 
Jolla, CA) were Lipofectamine LTX with Plus Reagent (ThermoFisher, Waltham , MA) 
transfected with 1μg of either DIO-V5-HDAC3W.T. or DIO-NURR2C-V5, with and without 1μg 
of CMV-Cre-GFP. 48 hours later, cells were harvested, lysed in tissue lysis buffer (T-PER, 
ThermoFisher; 1X HALT protease inhibitor), and probed for expression of V5-tag via western blot 
(mouse anti-V5, Invitrogen; 1:1000).  
Viral Packaging: 
AAV constructs were packaged as previously described308. Briefly, HEK293 cells were 
transfected via by standard calcium phosphate precipitation and grown in high-glucose-containing 
(4.5 g/liter) DMEM (Invitrogen) supplemented with 10% fetal bovine serum (Life 
Technologies/Invitrogen, Carlsbad, CA), 100 units/ml penicillin and 100 µg/ml streptomycin at 
37°C in a 5% humidifie.2 hours prior to transfection, HEK293 cells were bathed in 5% fetal bovine 
serum in 25mL IMDM (Invitrogen). Cells were transfected with: 12ml H2O, 1.65ml of 2.5M 
CaCl2, plus AAV1 (30ug), AAV2 (31.25ug) and helper plasmid (125ug), combined with target 
plasmid (62.5ug) either rAAV-hSyn-DIO-GFP rAAV-hSyn-DIO-HDAC3W.T., rAAV-hSyn-DIO-
HDAC3Y298H, or rAAV-hSyn-DIO-NURR2C. 13mL of 2x HEBS was vortexed into transfection 
buffer. 24 hours following transfection, cells were bathed in fresh DMEM. Following 60-65 hours, 
transfected HEK293 were harvested into PBS, pelleted, and resuspended in 150mM NaCl/20mM 
Tris. Cells were subsequently lysed in 10% NaDeoxycholate and 50U/ml benzonase. Cells were 
frozen at -20°C for at least 24 hours and virus was purified using Heparin columns. AAVs were 
concentrated using Amicon Ultra-4 concentrators. Viral titer was verified using qPCR. Briefly, 
AAVs were heat inactivated and nucleotide extracted with Proteinase K in ABI buffer (500mM 
KCL, 100mM Tris pH 8.0, 50 mM MgCl), incubated at 50°C for 1 hour and 95°C for 20 min. 
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Extracted nucleotides were serially diluted and underwent qPCR amplification to measure DNA 
concentration with primers designed to AAV ITRs. AAV titers are as follow: AAV-hSyn-DIO-
GFP, 5.34x1010; AAV-hSyn-DIO-HDAC3W.T., 1.15x109; AAV-hSyn-DIO-HDAC3Y298H, 
1.71x109; AAV-hSyn-DIO-NURR2C, 6.58x1010. 
Stereotaxic Surgeries: 
2-5-month-old heterozygous ChAT-Cre mice received 0.5μL bilateral infusions to the 
medial habenula (M/L, +/-0.35mm; A/P, -1.5 mm; D/V; -3.0) of AAV-hSyn-DIO-GFP (5.34x1010); 
AAV-hSyn-DIO-HDAC3W.T. (1.15x109); AAV-hSyn-DIO-HDAC3Y298H (1.71x109); or AAV-hSyn-
DIO-NURR2C, (6.58x1010). Viruses were infused at a rate of 100nl/min using a 30 gauge Neuros 
Hamilton syringe (product #65459-01) mounted to either a Harvard Apparatus Nanomite Syringe 
Pump (product #MA1 70-2217) or Leica Biosystems Nanoinjector Motorized f/Stereotaxics 
(product #39462901)293. All infusions used the Leica Microsystems Angle Two Stereotaxic 
System. For behavioral experiments, animals were allowed to recover for a minimum of 7 d before 
handling. 
CPP Reinstatement Paradigm:  
Cocaine-induced CPP was performed as previously described42,144,240,241. Briefly, animals 
were handled for 2 min for 3 consecutive days. Following handling, mice were conditioned over 
4 consecutive days, receiving either cocaine-HCl (10mg/kg, IP; Sigma) or 0.9% saline, in a 
context-dependent manner (counter-balanced, unbiased). Following conditioning, animals were 
allowed to freely explore, in a drug-free state, the complete chamber to assess preference, 
established as the difference between time spent in the cocaine-paired chamber and the saline-
paired chamber, in seconds. To extinguish preference, animals were repeatedly reintroduced to the 
chamber, daily for 6 consecutive days. Once extinguished, animals received a priming dose of 
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cocaine-HCl (5mg/kg, I.P.; Sigma) and immediately tested for reinstatement. Behavior was 
assessed and analyzed using Ethovision XT 11.5. 
Fluorescence Activated Cell Sorting (FACS): 
 45 minutes following the completion of cocaine-primed reinstatement, animals (2-
3/sample) were euthanized and Hb tissue was harvested into 1mL ice-chilled HABG (200μl 50X 
B27; 25μl 100X Glutamax; in 9.8 ml of Hibernate A cell media. Single cell lysates were generated 
as previously described309. Briefly, tissue was aspirated into 2mL papain buffer (14ul 100X 
Glutamax; 110U papain; 200U DNAse; in 5.5ml Hibernate E cell media) and incubated at 32°C 
for 15 min with gentle rotation. Tissue was transferred into ice-chilled HABG + 1X protease 
inhibitor and gently triturated until larger pieces no longer visible. The 2ml Cell suspension was 
passed through a 70μm cell filter and filter was washed with an additional 5ml, to generate a final 
7ml suspension. Cells were then pelleted and magnetically demyelinated using Myelin Removal 
Beads II (MACS Miltenyi Biotec). MHb TdTomato+ neurons were sorted and collected using the 
BD FACS Aria II Cell Sorter in collaboration with the Sue and Bill Gross Stem Cell Research 
Center at the University of California, Irvine.  
Chromatin Immunoprecipitation qPCR (ChIP-qPCR): 
MHb TdTomato+ neurons were collected into 250ul 2X MNase buffer (100mM Tris pH 
8.0, 2mM CaCl2, 0.4% Triton X-100) and diluted to a final volume of 500ul with nuclease free 
water. 15ul of diluted MNase (2000U MNase into 500uL 1X MNase buffer) was added to isolated 
cells and incubated at 37°C for 5 min. MNase was inactivated with 50ul of 10X MNase stop buffer 
(110mM Tris pH 8.0, 55mM EDTA). To lyse neurons, 550ul of 2X RIPA buffer (280mM NaCl, 
1.8% Triton X-100, 0.2%SDS, 0.2% Na Deoxycholate, 5mM EDTA) was added and cells were 
incubated on ice for 15 min. Samples were centrifuged (13,000RPM, 10 min, 4°C) and supernatant 
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aliquoted for immunoprecipitation using the Millipore ChIP Kit. 5ul of total was set aside for Input 
positive control while 500ul of sample were incubated overnight at 4°C with 20ul Protein A 
(Invitrogen) beads, 5.25uL 100X protease inhibitor, and 5uL of anti-HDAC3 (Millipore) or anti-
mouse IgG negative control (Millipore). The following day samples were precipitated on a chilled 
magnet and washed for 5 minutes in 500ul of the following wash series: Low Salt Immune 
Complex, High Salt Immune Complex, LiCl Immune Complex Wash Buffer, lastly TE Buffer. 
Immediately following the final wash, samples were magnet-precipitated, eluted from magnetic 
beads 100ul Elution Buffer (containing 1ul 100X Proteinase K), and DNA column purified. 
Enrichment at cFos, Nr4a2, Cebpb, Ppp1r1b (gene coding for DARPP-32), and Nr4a3 promoters 
was measured via qPCR using the Roche 480 LightCycler and SYBR green systems. Promoter 
specific primer sequences were designed using Primer3 and are as follows: cFos, Forward 5’ – 
tacgaccccttcaggcatac- 3’, Reverse 5’ – gttttaaaggacggcagcac – 3’; Nr4a2, Forward 5’ – 
gcgagtgttcttttccgttc – 3’, Reverse 5’ – tgaagtccgtggtgatgcta – 3’; Cebpb, Forward 5’ – 
acctgggtgggaggacat – 3’, Reverse 5’ – atcgttcctccagctacacg – 3’; Ppp1r1b, Forward 5’ – 
ggcctcccttaaaagtccac – 3’, Reverse 5’ – ttaatgaagtccagcggtga – 3’; and Nr4a3, Forward 5’- 
gagggaggaggagggtgacgta – 3’, Reverse 5’ – catagagtgcctggaatgcgaga – 3’.  
ChIP-qPCR data was normalized using the percent input method; Input sample was 
adjusted to 100% and IP samples were calculated as a percent of Input using the following: 
100*AE^(adjusted input – Ct (IP)). Fold enrichment was calculated as a percentage of total 
Input. AE = in-plate standard curve determined amplification efficiency. 
Quantitative RT-PCR 
 RT-qPCR was performed to confirm cell identity of FACS isolated MHb 
TdTomato:ChAT+ neurons. Single cell lysates collected from the MHb of TdChAT animals 
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were FACS isolated into RLT buffer. RNA was isolated using the RNeasy Minikit (Qiagen) and 
cDNA was generated using High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems). The following primers were used, derived from the Roche Universal Probe Library: 
ChAT Forward: 5’ – ttttgatggcatcgtcctg – 3’, Reverse: 5’ – acgagcttcttgttgcctgt – 3’, used with 
Roche Probe #62; Syt9 Forward: 5’ – ggagaactgtgcccatgc – 3’, Reverse: 5’ – 
tgagctgtcttcggattgag – 3’, used with Roche Probe #21; Hprt5 Forward: 5’ – tgctcgagatgtcatgaagg 
– 3’, Reverse: 5’ – cttttatgtcccccgttgac – 3’, used with Probe 5’HEX-atcacattgtggccctctgt -3’. 
Loose-cell patch clamp electrophysiology 
Coronal slices (250–300μm) through the epithalamus were collected via vibratome and 
transferred into 1X ACSF containing the following (in mM): 124 NaCl, 3 KCl, 1.25 KH2PO4, 1.5 
MgSO4, 26 NaHCO3, 2.5 CaCl2, and 10 dextrose. Recordings were made in a submerged 
chamber superfused at 2-3 ml/min with carbogen-saturated 1X ACSF 32°C. Labeled neurons of 
the medial habenula were identified by using an upright fluorescence microscope. Loose cell 
attached recordings (110–250 MΩ) were achieved from identified fluorescent cells by using 
infrared differential interference contrast. Recordings (Axopatch 200A amplifier) were made 
with 5–7MΩ pipettes filled with 0.9 percent NaCl (saline). Data were analyzed with pClamp 
(Molecular Device) and Minianalysis (Synaptosoft) 
Immunohistochemistry: 
Animals were euthanized and brains flash frozen in dry ice-chilled isopentane. 20μM 
coronal sections were collected using a Leica CM 1850 cryostat at -18°C. For 
immunohistochemical confirmation of V5-tagged viruses, MHb containing slices were fixed in 
4% PFA for 10 min, washed in 0.1M PBS, and permeated in 0.1% Triton X-100 in 0.1M PBS. 
Slices were then blocked in blocking serum (8% NGS, 0.3% Triton X-100, in PBS; 1 hr) and 
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incubated at 4°C overnight in primary solution (2% NGS, 0.3% Triton X-100; Rabbit anti-V5 
[1:1000], abcam #9116). Slices were then incubated in secondary solution (2% NGS, 0.3% Triton 
X-100; V5, Alexa Fluor goat anti-rabbit 555; in PBS). Tissue was imaged using Olympus Slide 
Scanner VSBX61.  
Results 
FACS-ChIP-qPCR can be used to asses HDAC 3 occupancy in the vMHb 
 Cocaine-primed reinstatement increases H4K8Ac throughout the MHb (Chapter 
1), suggesting a disengagement of HDAC3 activity. Although we have also linked changes in MHb 
cholinergic function to reinstatement behavior, it is unknown if HDAC3 function is altered in the 
same cholinergic population (Chapter 3). Thus, to measure HDAC3 enrichment in only the 
cholinergic neurons in the MHb, we crossed the LSL-TdTomato mouse line to the ChAT-Cre 
mouse line. This cross-bred TdChAT mouse line limits expression of the fluorescent TdTomato 
reporter to cholinergic neurons, especially in the vMHb (Fig. 4.1A). Using RT-qPCR, we 
confirmed that TdTomato:ChAT+ neurons can be sorted from the vMHb of TdChAT mice (Fig. 
4.1B). Moreover, in home cage animals, we detected HDAC3 occupancy at the promoters of 
Nr4a2, Darpp32, and cFos (Fig 4.1C). These results demonstrate the ability to use TdChAT mice 
Figure 4.1: MHb ChAT neurons can be isolated via FACS. (A) TdChAT animals express TdTomato reporter in 
cholinergic neurons of the MHb. (B) FACS isolated TdTomato+ MHb neurons show increased enrichment for ChAT 
compared to unsorted habenula containing tissue. (C) At baseline, HDAC3 occupancy can be detected at the promoters of 
Nr4a2, Ppp1r1b (Darpp32), and cFos in FACS sorted TdTomato+ MHb neurons. (** indicates p ≤  0.01 
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combined with FACS-ChIP-qPCR to examine HDAC3 occupancy in the cholinergic neurons of 
the MHb in a gene-specific manner.  
HDAC3 occupancy is altered in the vMHb during cocaine-primed reinstatement of CPP 
 To determine if HDAC3 occupancy is altered during cocaine-primed reinstatement, 
TdChAT animals underwent cocaine-primed reinstatement. TdChAT animals acquire (Fig. 4.2A) 
and extinguish (Fig. 4.2B) cocaine-induced CPP. 24 hours following the final extinction session, 
animals were primed with either saline or cocaine-HCl (5mg/kg, I.P.) and immediately tested. 
Cocaine-primed animals show a significant reinstatement of preference score compared to saline-
primed controls (Fig. 4.2C). 45 minutes following reinstatement session, animals were sacrificed, 
Hb tissue was harvested, and single-cell lysates were FACS sorted. Cocaine-primed animals show 
a significantly decreased HDAC3 occupancy at the promoter of Nr4a2 (Fig. 4.2D) compared to 
Figure 4.2: HDAC3 occupancy is altered in the MHb in response to cocaine-primed reinstatement. TdChAT mice 
(A) acquire cocaine-induced CPP (Two-way ANOVA, main effect of Conditioning: F(1, 16)=29.33, p<0.0001), with no 
differences between saline-primed (n=7) and cocaine-primed animals (n=11) (Two-way ANOVA, No main effect of 
Reinstatement-Priming: F(1,16)=3.347, p=0.0860; although there is a trend, there is no Interaction between effects, 
F(1,16)=0.4218, p=0.5253 and the trend is likely being driven by variability in Pre-Test score). (B) CPP can be extinguished 
with repeated drug-free exposures to conditioning apparatus (Two-way ANOVA, main effect of Extinction F(5,80)=8.023,  
p<0.0001). (C) Cocaine-primed animals significantly reinstate previously extinguished cocaine-induced CPP compared 
to saline-primed controls (Two-way ANOVA, main effect of Cocaine-Priming: F(1,16)=8.389, p=0.0105; trending 
Interaction F(1,16)=4.173, p=0.0579; Sidak’s Post-hoc analysis shows a significant difference between saline-primed 
animals and cocaine-primed animals during reinstatement session t(32)=3.544, p=0.0025 but not during E6 t(32)=1.215, 
p=0.4120). ChIP-qPCR shows HDAC3 occupancy is significantly lower in cocaine-primed animals at the (D) Nr4a2 
promoter (t(5)=2.802, p=0.0379), with no differences at the promoters of (E)  Ppp1r1b (t(5)=0.737, p=0.4961), (F) Cebpb 
(t(5)=1.919, p=0.1131), and (G) Nr4a3 (t(5)=1.298, p=0.2508). (* indicates p ≤ 0.05, **** indicates p ≤ 0.0001) 
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saline-primed controls. No significant change was observed at other HDAC3 target genes known 
to be critical in associative plasticity including Ppp1r1b (DARPP-32; Fig. 4.2E), Cebpb (NR4A2-
target gene; Fig. 4.2F), and Nr4a3 (Nr4a family member; Fig. 4.2G). Thus, HDAC3 disengages 
from the promoter of Nr4a2 and leaves Nr4a2 in a transcriptionally-permissive state in the MHb 
during cocaine-primed reinstatement. However, whether this change in MHb HDAC3 function is 
necessary for reinstatement behaviors remains unclear. 
Loss of HDAC deacetylase activity in the MHb alters cocaine-associated memories 
 To determine if HDAC3 deacetylase activity is necessary for MHb-mediated reinstatement 
behavior, we developed a viral vector approach to overexpress either HDAC3W.T. or a loss of 
function HDAC3 point-mutant, HDAC3Y298H. The Y298H point mutation has been shown to 
generate a loss of HDAC3 deacetylase function117 and has been shown in vivo to affect histone 
acetylation and learning processes306. To limit expression to the cholinergic neurons of the MHb, 
HDAC3W.T. and HDAC3Y298H were cloned into Cre-dependent constructs (Fig. 4.3A-C). ChAT-
Cre mice were subsequently injected in the MHb with either DIO-GFP or DIO-HDAC3Y298H and 
underwent cocaine-primed reinstatement. Although both GFP and HDAC3Y298H injected animals 
Figure 4.3: Expression of DIO-HDAC3W.T. and -HDAC3Y298H is limited to Cre-expressing cell populations. (A). 
Western blot probing for V5-tagged constructs expressed in HT22 cells. DIO Expression is limited to co-expression of 
Cre-recombinase and detected V5+ signal occurs at the predicted molecular weight of HDAC3 (50kD). (B) 
Representative image of DIO-HDAC3W.T.-V5 expression (gold) in the MHb of ChAT-Cre mouse. (C) Representative 
image of DIO-HDAC3Y298H-V5 expression (red) in the MHb of ChAT-Cre mouse. Note limited expression to the 
vMHb, where the cholinergic MHb population is enriched. 
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equally acquired (Fig. 4.4A), animals injected with HDAC3Y298H showed a significant impairment 
in extinction (Fig. 4.4B). Because these HDAC3Y298H had a significant impact on extinction, 
interpretation of reinstatement behaviors is severely confounded.  
HDAC3 overexpression has no effect on MHb-mediated cocaine-associated behaviors. 
 To determine if disengagement of HDAC3 in the MHb is necessary for cocaine-primed 
reinstatement, we infused either DIO-GFP or DIO-HDAC3W.T. into the MHb of ChAT-Cre mice. 
DIO-GFP and DIO-HDAC3W.T. equally acquired (Fig. 4.5A) cocaine-induced CPP. However, 
unlike HDACY298H (see Fig. 4.4B), overexpression of HDAC3W.T. in the MHb had no effect on 
extinction of cocaine-induced CPP (Fig. 4.5B). 24 hours following the final extinction session, 
both GFP and HDAC3W.T. expressing animals received a cocaine prime (5mg/kg, I.P.) and 
immediately tested for reinstatement. HDAC3W.T. in the MHb had no effect on cocaine-primed 
Figure. 4.4: Loss of HDAC3 deacetylase activity generates an extinction-resistant CPP. Animals 
infused with DIO-GFP (n=25) and DIO-HDAC3Y298H (n=22) equally (A) acquire cocaine-induced CPP 
(main effect of Acquisition, F(1.45)=94.43, p<0.0001, although trending effect of HDAC3Y298H 
F(1,45)=3.84, p=0.0563, no Interaction F(1,45)=0.347, p=0.5588). Although both groups (B) extinguish 
conditioned preference (main effect of Extinction F(5,225)=21.48, p<0.0001), animals expressing 
HDAC3Y209H show blunted extinction of cocaine-induced CPP compared to GFP (main effect of Y298H 
F(1.45)=4.264, p=0.0447; Sidak’s posthoc analysis demonstrates a significant difference at E6 
t(270)=2.711, p=0.0420). (* indicates p ≤ 0.05, **** indicates p ≤ 0.0001, ‡ indicates p ≤ 0.05 main effect 
of Y298H) 
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reinstatement of CPP (Fig. 4.5C), suggesting that HDAC3 activity in the MHb, alone, is 
insufficient to prevent relapse-like behaviors. 
Loss of NR4A2 function in the MHb impairs cocaine-primed reinstatement of CPP  
 HDAC3 has been previously shown to be a powerful negative regulator of plasticity and 
associative processes, through negative regulation of Nr4a2. While Nr4a2 is enriched in the 
vMHb, little is known about NR4A2 function in the adult habenula. Previous work has shown that 
an endogenously occurring Nr4a2 splice-variant, NURR2C, blocks NR4A2-dependent 
transcription 307. However, it is unknown if NURR2C functions as a direct dominant-negative to 
NR4A2 activity. First, to determine if NURR2C directly interacts with NR4A2, we expressed V5-
NURR2C with or without untagged NR4A2 in HT22 cells. 48 hours following transfection, we 
immunoprecipitated V5-NURR2C using a V5-specific antibody and immunoblot analysis of V5-
precipitates identified a ~65kD NR4A2-immunoreactive band (Fig. 4.6A-B), demonstrating a 
direct NURR2C/NR4A2 interaction. 
To determine the role of NR4A2 in vMHb function, we cloned a Cre-dependent NURR2C 
expressing vector (Fig. 4.6C). NURR2C is an endogenously occurring splice-variant of NR4A2 
that has been shown to block NR4A2 transcription factor activity307. This viral strategy allows 
limited overexpression of V5-NURR2C to the cholinergic neurons of the vMHb in ChAT-Cre 
Figure 4.5: HDAC3W.T. in the MHb does not affect cocaine-associated behaviors. Animals infused with 
DIO-GFP (n=15) and DIO-HDAC3W.T.(n=13) equally (A) acquire cocaine-induced CPP (main effect of 
Acquisition, F(1.26)=134.9, p<0.0001) and equally (B) extinguish (main effect of Extinction F(5,130)=28.8, 
p<0.0001). Both GFP and HDAC3W.T. equally reinstate preference following a cocaine-prime (main effect of 
Reinstatement F(1,26)=12.72, p=0.0014). (** indicates p ≤0.01, **** indicates p ≤ 0.0001) 
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mice (Fig. 4.6D). To determine the effect of loss of NR4A2 function on MHb cholinergic function, 
we co-expressed DIO-mCherry + DIO-V5-NURR2C or DIO-mCherry alone in the vMHb of 
ChAT-Cre mice. 4 weeks following viral infusion, loose seal clamp recordings were taken from 
Figure 4.6: Expression of DIO-Nurr2c in the vMHb alters cocaine-primed reinstatement behavior. HT22 cells 
either expressing V5-NURR2C alone (lane 1 and lane 2) or co-expressing V5-NURR2C and untagged NR4A2 (lane 3 
and lane 4). Cells underwent immunoprecipitation using anti-V5 and western blot probing for (A) NR4A2 (note 
NR4A2-immunoreactivity ~65kD) or (B) V5 (Note V5-NURR2C immunoreactivity ~55kD and absence of NR4A2-
immunoreactivity ~65kD). (C). Western blot probing for V5-tagged constructs expressed in HT22 cells. DIO expression 
is limited to co-expression of Cre-recombinase and detected V5+ signal occurs at the predicted molecular weight of 
NURR2C (55kD). (D) Representative image of DIO-V5-NURR2C expression (teal) in the MHb of ChAT-Cre mouse. 
Note limited expression to the vMHb, where the cholinergic MHb population is enriched. (E) Overexpression of 
NURR2C blunts baseline firing rate of MHb cholinergic neurons (t(14.25)=2.473, p=0.0266). Animals infused with DIO-
GFP (n=16) and DIO-V5-NURR2C.(n=13) equally (F) acquire cocaine-induced CPP (main effect of Acquisition, 
F(1,27)=61.98, p<0.0001) and equally (G) extinguish (main effect of Extinction F(5,130)=21.95, p<0.0001; although there 
is an Interaction F(5,130)=2.371, p=0.0427, Sidak’s posthoc analysis indicates there is no significant difference between 
GFP and NURR2C expressing animals on any extinction session). Following extinction, NURR2C expressing animals 
showed a (H) significantly blunted cocaine-primed reinstatement compared to GFP controls (main effect of 
Reinstatement F(1,17)=10.36, p=0.0033; main effect of NURR2C F(1,27)=6.599, p=0.0160; Sidak’s posthoc analysis 
significant difference between GFP and NURR2C during reinstatement t(54)=2.3, p=0.05). (* indicates p ≤ 0.05, ** 
indicates p ≤ 0.01, **** indicates p ≤ 0.0001, ‡ indicates main effect of Nurr2c) 
91 
 
mCherry labeled neurons in coronal slices through the MHb. Cells co-expressing DIO-mCherry + 
DIO-V5-NURR2C had a significantly decreased baseline firing rate compared to cells expressing 
DIO-mCherry alone (Fig. 4.6E), suggesting NR4A2 function is necessary for maintenance of MHb 
firing. 
To determine the role of NR4A2 in MHb-mediated relapse-like behaviors, we infused 
either DIO-GFP or DIO-NURR2C into the MHb of ChAT-Cre mice. NURR2C had no effect on 
the acquisition (Fig. 4.6F) or extinction (Fig. 4.6G) of cocaine-induced CPP. Following extinction, 
animals received a cocaine prime (5mg/kg, I.P.) and were immediately tested for reinstatement of 
conditioned preference. NURR2C expressing animals showed a blunted reinstatement compared 
to GFP expressing controls (Fig. 4.6H). This work demonstrates that NR4A2 transcription factor 
activity is necessary in the cholinergic neurons of the MHb for cocaine-primed reinstatement of 
CPP. 
Discussion 
 Our previous work has demonstrated that the MHb is engaged during cocaine-primed 
reinstatement of CPP. Specifically, we show increases in H4K8Ac, an epigenetic mark negatively 
regulated by HDAC3 and positively correlating with increased Nr4a2 expression. Previous work 
from the Wood lab and others have demonstrated that HDAC3 is a negative regulator of long-term 
memory in the hippocampus and amygdala and a regulator of cocaine-associated behaviors in the 
NAc, primarily through negative regulation of Nr4a2112,135,310. Here, we demonstrate that during 
cocaine-primed reinstatement, HDAC3 disengages from Nr4a2 in the cholinergic population of 
the MHb, aligning with the global increases in H4K8Ac. We detected no changes in other known 
HDAC3 target genes enriched in the MHb that are known players in cocaine response and 
plasticity (including Cebpb and Ppp1r1b), providing further evidence for HDAC3 functioning as 
92 
 
a molecular brake pad through negative regulation of Nr4a2. However, given the global changes 
in histone acetylation observed, it is unlikely that Nr4a2 is the only gene with decreased HDAC3 
occupancy. It is not completely surprising that we did not detect changes in Ppp1r1b 
transcriptional regulation, as various groups have shown the phosphorylation state of DARPP-32 
is more relevant to its function than up or downregulation of its transcript. To fully characterize 
the array of HDAC3-regulated genes that are altered in the MHb during cocaine-primed 
reinstatement, future studies should employ a less hypothesis-drive approach, such as next 
generation ChIP-Sequencing.  
We characterize the function of HDAC3 deacetylase activity in the MHb during cocaine-
associated behaviors. Whereas loss of HDAC3 deacetylase activity in the vMHb (through 
overexpression of HDAC3Y298H) had no effect on acquisition of cocaine-induced CPP, 
overexpression of HDACY298H blunted extinction of CPP, thus preventing effective 
characterization of the role of HDAC3 in regulating reinstatement. As other gain of function 
manipulations in the vMHb (such as optogenetic stimulation) accelerate extinction memory200, it 
is surprising that loss of deacetylase activity would blunt extinction of CPP. Due to the 
experimental design (where viruses were delivered prior to CPP procedure), it is unclear if 
HDAC3Y298H in the vMHb is affecting the extinction process (that is, the formation of extinction 
memory) or if it is generating a CPP that is stronger and therefore resistant to extinction. One may 
expect this effect to be parsed with differences in acquisition of CPP (that if HDACY298H in the 
vMHb is strengthening acquisition, it should generate a higher preference score during the 
Posttest), yet it is likely that the conditioning dose used in these experiments (10mg/kg) is 
generating a ceiling effect preventing any super-induction in preference score during acquisition. 
Future studies can more fully characterize a role of HDAC3 in the MHb during acquisition using 
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subthreshold doses for cocaine-induced CPP (e.g. 2.5 and 5 mg/kg) Moreover, the mechanisms 
underlying this effect remain undetermined, but is likely to be mediated by other non-NR4A2 
HDAC3 gene targets (as loss of NR4A2 does not appear to affect extinction). Endogenously, 
HDAC3 provides negative regulation to various genes in the vMHb, and specifically disengages 
from select genes (such as Nr4a2) when the MHb is engaged, such as during cocaine-primed 
reinstatement. Global loss of HDAC3 deacetylase activity possibly allows the expression of 
several genes negatively regulated by HDAC3 prematurely altering MHb function generating 
effects on extinction behavior. 
 Additionally, HDAC3W.T. had no effect on the acquisition, extinction, or reinstatement of 
cocaine-induced CPP. While, again, it is possible the conditioning dose (10mg/kg) is too strong to 
detect subtle changes in acquisition, previous work has demonstrated that HDAC3 deacetylase 
activity is dependent on the formation of a complex with co-repressors NCoR and SMRT79,311. 
Moreover, as HDAC3 does not in and of itself have a DNA binding domain for gene specific 
targeting, overexpression of HDAC3W.T. without combinatorial overexpression of NCoR and 
SMRT is unlikely to have a significant effect on deacetylase activity. Future studies should more 
thoroughly evaluate what role HDAC3 in the MHb may have on the regulation of acquisition and 
extinction of CPP. With the advent of CRISPR/dCas9 technology, future studies will be able to 
specifically target either HDAC3W.T. or HDAC3Y298H to the Nr4a2 locus to determine if HDAC3 
negative regulation of Nr4a2 is necessary and sufficient for cocaine-primed reinstatement. 
Lastly, we evaluate what role NR4A2 may have on vMHb regulated behaviors. NR4A2 is 
an immediate early gene and transcription factor that has a versatile role throughout the CNS. It 
has been shown to be required for long-term memory formation in the hippocampus25,26,28. Also, 
NR4A2 is necessary for proper development of dopaminergic neurons and has been shown to be 
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dysregulated throughout the ventral midbrain and ventral striatum following chronic cocaine 
administration16,32,312. Whereas NR4A2 is known to also be required for proper MHb 
development173, its role in the adult MHb remains unknown. Previous work demonstrates that 
Nr4a2 is induced in the MHb following an associative learning paradigm, but does not provide a 
causal link between NR4A2 function and MHb-mediated behaviors 197. Here, we demonstrate for 
the first time that NURR2C directly interacts with endogenous NR4A2. Moreover, loss of NR4A2 
function via NURR2C overexpression blunts the canonical baseline firing rate in MHb cholinergic 
neurons and, subsequently, overexpression of NURR2C in the cholinergic neurons of the MHb 
blocks cocaine-primed reinstatement. These results provide evidence that 1) NR4A2 is critical in 
endogenous MHb function and activity 2) NR4A2 function is required for MHb-mediated relapse-
like behaviors. Yet, how NR4A2 affects MHb circuit function, what is NR4A2’s contributions to 
MHb firing, and which gene targets of NR4A2 are subsequently engaged during cocaine-primed 
reinstatement remain key open questions. Cebpb, an NR4A2 target gene22, was one potential 
candidate gene for conferring changes in the epigenome to changes in circuit function. Cebpb 
expression is known to be activity dependent and it is required for plasticity and hippocampal long-
term memory313,314. Moreover, CEBP/β is a transactivator of genes associated with cholinergic 
signaling enriched in the vMHb (such as Vacht and Chat315). However, as we detected no changes 
in HDAC3 occupancy during cocaine-primed reinstatement, these and other NR4A2 target genes 
may regulate vMHb function at a different time point, if at all. Also, it is possible our dominant-
negative approach using NURR2C only affects a subset of NR4A2-dependent gene targets. The 
NR4A family of transcription factors are known to form homo- and heterodimers to regulate 
transcription27; while NURR2C has been demonstrated to block known NR4A2-target genes307 it 
is unknown if NURR2C impact the function of NR4A2-containing heterodimers. Identifying the 
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full library of NR4A2 regulated genes and isolating those which contribute to adult MHb 
cholinergic function will be a critical step forward in understanding the MHb’s contributions to 
relapse-like behaviors and SUD at large. Still, in the MHb, HDAC3 functions as a negative 
regulator of Nr4a2 that is disengaged during cocaine-primed reinstatement. 
The MHb has become a focus for addiction researchers over the past decade. The presented 
studies further link MHb function with relapse-like behaviors by identifying a key molecular 
mechanism, in HDAC3-dependent regulation of Nr4a2, underlying cocaine-primed reinstatement 
of conditioned place preference. Moving forward, identifying the downstream targets of HDAC3 
and NR4A2 that may confer cocaine-induced changes to MHb circuit function will provide a novel 
avenue of studies regarding the molecular and circuit mechanisms regulating MHb activity during 
relapse and relapse-like behaviors.  
  
96 
 
Chapter 5: Conclusions and Moving Forward 
While there are therapeutics of varying efficacy, SUD is a chronically relapsing disease 
with no current cure. Drugs of abuse establish long-lasting changes to various neural pathways and 
the underlying molecular mechanisms which control neural circuit function. These changes are 
believed to generate the resilience and persistence of drug-seeking behavior, even following long-
periods of abstinence. Of note is the ability of drug-associated cues or even brief drug re-exposures 
to elicit powerful cravings and drive relapse. As such, researchers have continued to characterize 
the various adaptations in response to both acute and repeated drug exposures that provide the 
persistence of these drug associations. 
Epigenetic mechanisms are powerful regulators of the molecular adaptations induced by 
drugs of abuse. Often, epigenetic modifiers themselves are recruited and can provide long-lasting 
changes in gene expression profiles throughout the CNS. Volumes of research in the mesolimbic 
pathway (including the VTA and NAc) demonstrate drug-induced epigenomic changes that may 
provide the persistence and resilience of drug-seeking behavior, including loci-specific changes to 
histone modifications (such as acetylation, methylation, and phosphoacetylation)32,133,134. Of note 
is the altered HDAC3 function and the regulation of its target genes, such as Nr4a2, seen 
throughout various cocaine-associated behaviors135,240,316. Recent work has begun to explore the 
epigenetic regulation of neural pathways that feed into the mesolimbic dopamine system and 
regulate drug-associated behaviors. The work in this dissertation focused on the epigenetic 
adaptations in the MHb that lead to cocaine relapse-like behaviors. 
The MHb is a small, often ignored, epithalamic region. Canonically characterized as an 
aversion hub, more recent work has refined the function of the MHb as a region that responds to 
aversive associations to generate adaptive responses197,199,200. Regarding SUD, the MHb has 
garnered significant attention from nicotine researchers, as the MHb-IPN pathway shows the 
97 
 
densest nAChR expression. Of note are the vMHb α5- and β-4 subunit containing nAChRs, as 
these subunits are critical regulators of nicotine withdrawal, nicotine aversion, and nicotine 
mediated anxiety-like behaviors210,215,290,291,302. While the endogenous function of the MHb 
remains elusive, the work presented above provides further evidence of the MHb’s role in 
regulating drug-associated behaviors.  
 A clear role for the vMHb in regulating the responses to other drugs of abuse, such as 
cocaine, remains undefined, at best. The results presented in this dissertation broaden the known 
role of the vMHb in relapse-like behaviors by 1) confirming previous work demonstrating the 
MHb is engaged during reinstatement of cocaine associated behaviors234, 2) causally linking 
vMHb activity to reinstatement of cocaine-induced CPP, 3) demonstrating that epigenetic 
adaptations (via altered HDAC3 occupancy) regulate genes critical to MHb-function (Nr4a2) 
during relapse-like behaviors, and 4) causally linking NR4A2 function to MHb-mediated cocaine 
relapse-like behaviors. Although the results of this dissertation provide a significant advance in 
the knowledge of the neural circuitry and epigenetic adaptations regulating relapse behaviors, there 
remains several key open questions.  
In Chapter 1, we assess the functional response of the MHb to various cocaine treatments. 
Whereas the MHb appeared insensitive to acute cocaine or the consolidation phase of cocaine-
induced CPP, we demonstrate that the MHb responds to cocaine re-exposures. Specifically, we 
provide evidence that the MHb is engaged during cocaine-primed reinstatement of cocaine-
induced CPP, recapitulating previous findings234 that the MHb is engaged during relapse-like 
behaviors. However, what adaptations that occur during repeated cocaine-exposure and/or forced 
abstinence/extinction that leave the vMHb primed for reinstatement? Although we demonstrate 
adaptations that occur in the MHb during reinstatement (such as increased cFos expression 
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(Chapter 1), increased histone acetylation (Chapter 1), and HDAC3 disengagement from Nr4a2 
(Chapter 4)), are these adaptations occurring as a direct response to cocaine re-exposure or is the 
vMHb responding to long-lasting circuit adaptations occurring elsewhere (such as changes to the 
serotonergic, setpal, or raphe inputs)? Our electrophysiological recordings from the vMHb show 
that bath application of cocaine is unable to induce vMHb firing, acutely or following extinction 
of cocaine-induced CPP, suggesting that the changes seen in vMHb activity during cocaine-primed 
reinstatement are likely caused by changes in upstream signaling that subsequently engage MHb 
activity. Various neurotransmitter systems feed into the MHb vis the stria medullaris, including a 
dense serotonergic input. Future work should identify the source of altered signaling into the MHb 
as a potential mechanism for blocking relapse and relapse-like behaviors. Although others have 
shown repeated cocaine exposure can subsequently suppress MHb baseline activity, we did not 
see changes in baseline firing rates in the vMHb of animals with a cocaine treatment history 
(compared to naïve animals)232. This difference suggests that either 1) our cocaine treatment was 
not sufficient to induce previously reported changes in MHb activity (Hammer et al. found changes 
following 7 consecutive days cocaine administration, while our CPP-based exposure paradigm 
only administers 2 days of cocaine), 2) the period of forced abstinence (or the extinction process) 
allows MHb activity to stabilize or 3) the MHb is sensitive to other differences in the schedules of 
cocaine treatment (such as dose). If vMHb activity were to stabilize during cocaine abstinence, 
there may be underlying epigenetic changes (that do not necessarily confer changes in neuronal 
activity) that prime the vMHb for cocaine-primed reinstatement.  
In Chapter 2, we use chemogenetics to causally link changes in neuronal activity to 
changes in associative behavior. We demonstrate that chemogenetic activation of the dorsal 
hippocampus enhances long-term memory for the object location, but not object recognition task. 
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Further, chemogenetic inhibition of the dorsal hippocampus blocked long-term memory formation 
for the object location tasks but had no effect on object recognition memory. However, whereas 
the effects on hippocampal long-term memory were independent of viral promoter (i.e. hSyn-
HM3D and CamKIIα-HM3D both enhanced object location memory), the effects on synaptic 
plasticity diverged in a promoter-specific manner. Specifically, electrophysiological results were 
inverse of our prediction: chemogenetic activation using hSyn-HM3D lead to inhibition of local 
field potentials and theta-burst induced LTP, whereas hSyn-HM4D lead to enhancement of local 
field potentials and theta-burst induced LTP. Use of the non-cell-type specific hSyn promoter 
(although the author will note that the hSyn promoter provides specificity to neurons) allowed 
DREADD expression in both the glutamatergic and GABA-ergic neuronal populations in the 
dorsal hippocampus. Chemogenetic manipulations on the GABA-ergic neurons of the dorsal 
hippocampus likely underlie this unique electrophysiological effect. However, it remains unclear 
how electrophysiological inhibition caused by hSyn-HM3D led to the enhancements observed in 
hippocampal long-term memory. As synaptic plasticity and LTP are proposed mechanisms for 
long-term memory formation, future studies should explore this disconnect between chemogenetic 
induced synaptic plasticity and chemogenetic-mediated changes to long-term memory formation. 
Our work (Chapter 1) has shown that the MHb is activated in response to cocaine-primed 
reinstatement of CPP. Moreover, the MHb has been previously shown to be engaged during cue-
primed reinstatement of cocaine self-administration. However, these changes in MHb activity have 
not been causally linked to changes in cocaine-associated behaviors. In Chapter 3, we use 
chemogenetics to causally link vMHb activity to reinstatement of cocaine-induced CPP. 
Specifically, chemogenetic activation of the cholinergic neurons in the MHb (concentrated in the 
vMHb) induces reinstatement of a conditioned preference, even in the absence of cocaine. 
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However, chemogenetic activation of the vMHb alone is unable to induce a conditioned 
preference. This suggests that vMHb activity is critical in regulating previously formed 
associations, but does not acutely generate preference or aversion. However, because we failed to 
observe electrophysiological changes in MHb firing during bath application of cocaine (both 
acutely or during cocaine re-exposure, Chapter 1), it is unclear if the firing rate induced 
chemogenetically is comparable to the endogenous increase in activity during cocaine-primed 
reinstatement. Lastly, the downstream effects of the observed changes in vMHb activity on IPN 
circuitry and function remain unexplored. The GABA-ergic neurons of the IPN regulate various 
brain regions and neurotransmitter systems all linked to cocaine-associated behaviors (including 
the ventral hippocampus and serotonergic neurons of the raphe nuclei). A more thorough 
characterization of the MHb’s circuitry during cocaine-primed reinstatement, including regulation 
of downstream IPN targets,  will be necessary to form a more complete understanding of the 
vMHb’s role in regulating relapse-like behaviors. 
In Chapter 4, we characterize epigenetic gene regulation in the cholinergic neurons of the 
MHb during cocaine-primed reinstatement. Work from our lab has previously demonstrated 
changes in MHb histone acetylation in response to cocaine-primed reinstatement that has been 
previously correlated with changes in HDAC3 function and Nr4a2 expression. We demonstrate that 
in response to cocaine-primed reinstatement in the cholinergic neurons of the MHb, HDAC3 
disengages from the promoter of Nr4a2, but not other genes related to cocaine response and 
plasticity (e.g. Cebpb, Ppp1r1b, Nr4a3). To further elucidate the role of HDAC3 function in MHb-
mediated reinstatement, we generated wild-type overexpression or deacetylase-dead variants of 
HDAC3. We demonstrate overexpression of HDAC3W.T. had no effect on cocaine-associated 
behaviors, whereas loss of HDAC3 deacetylase activity (HDAC3Y298H) in the cholinergic neurons 
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of the MHb disrupts extinction of cocaine-induced CPP. Yet, the underlying cause of this change 
remains unexplored. It is possible that endogenous HDAC3 prevents the recruitment of MHb 
circuitry during extinction of cocaine-associated CPP, but loss of HDAC3 activity allows the 
premature expression of various genes artificially altering MHb function during extinction. 
Previous studies have shown that the vMHb is critical in extinction of learned-fear200. Future 
studies should evaluate if the vMHb is similarly engaged during extinction of drug-associated 
behaviors, such as CPP. Also, while we demonstrate gene-specific changes in HDAC3 occupancy, 
the totality of HDAC3 regulated genes that are altered during cocaine-primed reinstatement is 
currently unknown. Identifying other downstream HDAC3 targets and how they impact MHb 
function will provide a more thorough understanding of the various cocaine-induced adaptations 
throughout the circuitry regulating drug-cravings, drug-seeking, and drug-relapse.  
Lastly, Nr4a2 is an immediate-early gene that has been previously linked to plasticity, 
associative memory, dopamine signaling, and is disrupted by various cocaine insults. However, 
whereas NR4A2 is known to be necessary for neuronal development in the MHb, the role of 
NR4A2 in the adult MHb is unknown. To further characterize NR4A2 function in the adult MHb, 
we used a dominant-negative variant of NR4A2, NURR2C, in a cell-type specific fashion. For the 
first time we demonstrate that NURR2C directly interacts with NR4A2, confirming its 
characterization as a dominant-negative. Furthermore, by overexpressing NURR2C in the 
cholinergic neurons of the MHb, we determine that loss of endogenous NR4A2 activity disrupts 
MHb function. Via overexpression of dominant-negative NURR2C, first we show that the 
endogenous baseline firing rate of cholinergic MHb neurons is blunted with loss of NR4A2 
function. Secondly, we demonstrate that loss of endogenous NR4A2 activity prevents MHb-
mediated reinstatement of cocaine-induced CPP. These results provide, for the first time, a 
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function of NR4A2 in the adult MHb and causally link NR4A2 activity to MHb-mediated 
behaviors. 
Nevertheless, while it is convenient to rely on the changes to a known transcription factor 
(NR4A2), it is highly unlikely that Nr4a2 is the one and only HDAC3 target critical to MHb 
function in response to cocaine. The goal of neuroepigenetics should not merely be to identify 
changes in nuclear acetylation states that regulate the expression of well-characterized 
transcription factors. But, as a field, we should strive to identify how these changes in the nucleus 
actually confer long-lasting changes in the neural circuits regulating behavior. Future studies 
should focus on identifying the cell-type specific gene targets of NR4A2 that contribute to MHb 
circuit function. Combinatorial Chip-Seq and RNA-seq studies provide researchers the ability to 
identify changes to both HDAC3 and NR4A2 transcriptional regulation, while simultaneously 
generating a MHb-specific transcriptome during cocaine-primed reinstatement. Identifying these 
downstream adaptations provide a currently unexplored avenue of therapeutics to reverse the drug-
induced maladaptations leading to relapse.  
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